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ABSTRACT 
 
Biotin is a cofactor required by all three domains of life. It is an enzyme cofactor 
that acts as a “swinging arm” to transfer carboxyl groups in important metabolic 
pathways involving carboxylation, decarboxylation and transcarboxylation reactions. 
Despite its importance, the biotin biosynthetic pathway has only been fully characterized 
in Escherichia coli. Our current understanding of other possible biotin synthetic pathways 
remains incomplete since various biotin synthesizing organisms have diverse bio genes 
that are not homologous to those of E. coli. The diversity in pathways lies in the first 
stage of synthesis of a pimelate thioester moiety. Bacillus subtilis represents a group of 
microorganisms that follow a different pathway for biotin synthesis. Genetic and 
biochemical studies identified bioW and bioI as two genes required for pimeloyl-CoA and 
pimeloyl-ACP synthesis, respectively. The question of the significance of each gene is 
striking due to the redundancy of pimelate thioester generation. BioW, a structurally 
unique enzyme, remained to be fully characterized for its importance and enzyme 
activity. BioW enables B. subtilis to use free pimelic acid as a precursor for biotin 
synthesis unlike the case in E. coli. However, the source of pimelic acid is unknown in 
bacterial metabolism.  
 
My results show bioW is essential for biotin synthesis whereas bioI is dispensable. 
I uncovered a unique function of BioW as a proofreading enzyme of noncognate acyl-
adenylate substrates other than pimeloyl-adenylate to ensure proper initiation of biotin 
synthesis. I also report pimeloyl-CoA as the preferred substrate of B. subtilis BioF unlike 
E. coli BioF. My 13C-NMR studies of labeled biotin elucidated the presence of pimelic 
acid in the cells and provided direct evidence for generation of pimelate through fatty 
acid synthesis. Decreased biotin production in presence of fatty acid inhibitors further 
verified my findings to establish pimelic acid as a link between fatty acid synthesis and 
biotin synthesis. Hence, in this Thesis, I report my observations that answer long-
standing questions about bioW-bioI gene redundancy and pimelate source, to gain further 
understanding of biotin synthesis in B. subtilis.  
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CHAPTER 1 
INTRODUCTION 
 
DISCOVERY AND FUNCTION OF BIOTIN 
 
A cofactor is a chemical compound or a metal ion essential for the function of an 
enzyme. Biotin is a covalently bound cofactor required for the function of key metabolic 
enzymes that carry out carboxylation, decarboxylation and transcarboxylation reactions 
in fatty acid synthesis, amino acid metabolism, gluconeogenesis and other processes (67, 
121).  It was first discovered in 1901 as an unknown substance “Bios” that was required 
for growth of yeast (129). Over the following years, several researchers independently 
discovered biotin in different aspects. It was identified as coenzyme R, a respiratory 
factor essential for respiration of rhizobia (3). Kögl and coworkers associated the yeast 
growth factor to “biotin” that can be extracted from egg-yolk (68). It was extensively 
characterized as a curative factor (vitamin H) which could cure egg-white injury, a 
dermatitic disease, in rats (9, 49, 48) and chicks (28). Further study revealed that eating 
raw egg-whites facilitates the sequestration of dietary biotin by avidin, rendering it 
unavailable for its physiological function thereby inducing vitamin deficiency (47).  
 
With the demonstration of the identity of vitamin H and coenzyme R with biotin 
(46), the work on the elucidation of the structure of biotin escalated in the 1940s. 
Melville, Du Vigneaud and co-workers were instrumental in deciphering the correct 
structure of biotin (25, 26, 87). It consists of fused heterocyclic rings comprised of a 
ureido ring and a tetrahydrothiophene ring that is attached to a valeric acid side chain 
(Figure 1-1A). The ureido ring with carbonyl oxygen is planar while the 
tetrahydrothiophene ring is envelope-shaped with the sulfur protruding out of the plane 
(22). After the structure elucidation, the first chemical synthesis of biotin was described 
by Harris and coworkers in 1944 (50) and a process for commercial production of biotin 
by chemical synthesis was patented shortly thereafter (41). 
 
2 
 
Biotin is a molecule that is required in small amounts compared to other vitamins 
in carbohydrate, fat and protein metabolism. Hence, unlike other vitamins, it was thought 
to be involved in a cellular process specific to synthesis of essential metabolites (71). 
Consequently, the physiological role of biotin was identified in utilization of bicarbonate 
for carboxylation reactions in Lactobacillus arabinosum (51). Lynen and coworkers were 
instrumental in finally linking biotin to enzymes that conduct carboxylation reactions 
necessary for central metabolic processes (80).  In a physiologically active state, the 
carboxyl group in the side chain is attached to a ɛ-amino group of conserved lysine 
residue of biotin dependent enzyme subunit that enables it to act as a “swinging arm” to 
perform enzyme reactions (Figure 1-1B). For carboxylations, biotin protein ligase 
covalently attaches biotin onto biotin carboxyl carrier protein (BCCP) subunit of biotin-
dependent enzymes such as acetyl-CoA carboxylase, propionyl-CoA carboxylase, 
pyruvate carboxylase and 3-methylcrotonyl-CoA carboxylase (121). Biotin carboxylase 
(BC) subunit carboxylates N1 atom of the ureido ring using bicarbonate as the CO2 
donor. Carboxyl transferase (CT) subunit then transfers the carboxyl group from 
carboxybiotin to the cognate substrate. Biotin is used as a cofactor by oxaloacetate 
decarboxylase to couple the decarboxylation of oxaloacetate to sodium translocation 
across the cell wall (72). Biotin dependent transcarboxylases from Propionobacterium 
shermanii can transfer carboxyl groups reversibly from 2-methylmalonyl-CoA to 
pyruvate to produce propionyl-CoA and oxaloacetate (94, 120). Hence, biotin plays a 
significant role in primary metabolism important for the survival of a wide range of living 
organisms.  
 
BIOTIN SYNTHESIS 
 
The biotin biosynthetic pathway is widespread among bacteria, archaea, fungi and 
plants (110). Mammals cannot synthesize biotin and hence require biotin to be ingested. 
Biotin synthesis pathway was first studied in Escherichia coli by Campbell and 
coworkers who identified ten bio mutants that require biotin from growth in minimal 
media and eluded to at least four genes mediating the process of synthesis (20). A year 
later, Eisenberg and coworkers identified a four step synthetic pathway, pimeloyl-CoA to 
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biotin, by performing cross-feeding assays, analyzing excretion products and growth 
responses to biotin vitamers (intermediates in biotin synthesis pathway) of sixty E. coli 
bio mutants (111). Deletion and complementation analysis led to the first identification of 
bio genes, namely bioA, bioB, bioF, bioC and bioD, in a single operon in E. coli (17). 
This provided a strong groundwork for further extensive studies on the genetic and 
biochemical aspects of microbial biotin synthesis pathway. The biotin synthesis pathway 
has been studied in several microbes; however, the only fully characterized pathway is 
that of E. coli (75). The general pathway can be separated into two stages. Four well-
conserved genes — bioF, bioA, bioD and bioB — are involved in the second stage in 
which the fused rings are assembled (Figure 1-2). The genes involved in the first stage of 
the pathway that generate pimelate thioester intermediates are quite diverse among 
different organisms, which will be discussed later in this chapter. 
 
The Conserved Second Stage of Synthesis 
The conserved genes involved in the second stage of the pathway were first 
characterized in E. coli. Since then, numerous other studies have shown the conservation 
of genes bioF, bioA, bioD and bioB in all biotin-synthesizing organisms known, 
including Bacillus subtilis (83, 110) (Figure 1-2). This section of the pathway begins with 
the incorporation of a pimelate (a seven carbon α, ω-dicarboxylic acid) thioester to 
eventually generate the heterocyclic rings of biotin in four enzymatic steps. One of the 
first demonstrations of biochemical activity was shown when pimeloyl-CoA and L-
alanine were successfully converted to 8-amino-7-oxononanoic acid by E. coli cell free 
extracts, now known to be the function of BioF (29). Since then, E.coli has been used as a 
model organism to characterize all four enzymes that share sequence, structure and 
function to a high degree across organisms.  
 
The first step of the second stage is catalyzed by BioF, a 8-amino-7-oxononanoate 
synthase. It catalyzes the formation of 8-amino-7-oxononanoate (also known as 7-keto-8-
aminopelargonic acid, KAPA) from pimelate thioester. The enzymatic activity of BioF 
has been studied extensively in several organisms including Bacillus sphaericus (60, 106, 
105), and the crystal structures of BioF from E. coli and Mycobacterium smegmatis are 
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available (2, 34). BioF belongs to a subclass II aminotransferase family of pyridoxal-5`-
phosphate (PLP) dependent enzymes that catalyze condensation between an amino acid 
and a carboxylic acid CoA thioester of resulting in decarboxylation of the amino acid. It 
is a homodimeric protein with each dimer consisting of three domains — N-terminal, 
central and C-terminal — shaped like an open left hand (2). PLP is bound to a conserved 
lysine residue that plays a role in binding the substrate l-alanine, while phosphate groups 
of pimeloyl-CoA are thought to bind to the region of enzyme rich in positive arginine 
residues (2). The active site residues are conserved within the family members which 
share the reaction mechanism that involves Schiff base chemistry (2).  
 
BioA is a 7, 8-diamino-nonanoate synthase that catalyzes the transformation of 8-
amino-7-oxononanoate to 7, 8-diamino-nonanoate (also known as 7, 8-diaminopelargonic 
acid, DAPA). It also belongs to PLP-dependent enzyme family of the subclass III 
aminotransferases (65). The enzymatic activity was first characterized in cell-free 
extracts of E. coli (101) and then in other organisms such as Mycobacterium tuberculosis 
(23) and B. subtilis (124). S-Adenosyl-L-methionine (SAM), a common methyl donor, is 
the amino donor for E. coli, B. sphaericus (59) and M. tuberculosis BioA which is the 
only enzyme known to use SAM as the amino donor. B. subtilis BioA, on the other hand, 
uses L-lysine as an amino donor (124). Van Arsdell and co-workers argued that the 
preference of BioA for SAM or lysine corresponds to the intracellular level of the amino 
donor in the cells. They speculated that E. coli and B. subtilis can maintain a limited flux 
through BioA reaction by having a Km value for the amino donor at equal or higher 
concentration than the intracellular pool, regardless of the type of amino donor (124). 
 
BioD is a dethiobiotin synthetase that catalyzes the ATP-dependent carboxylation 
of 7, 8-diamino-nonanoate to form dethiobiotin. Enzymatic and structural analysis of 
dethiobiotin synthase has been done in E. coli (69), M. tuberculosis (23) and 
Helicobacter pylori (108). This homodimeric enzyme belongs to the family of ATP-
dependent carboxylases that contains the classical mononucleotide-binding motif 
common to all ATP and GTP-binding proteins (53). BioD represents the third mechanism 
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of carboxylation reaction other than those carried out by biotin dependent carboxylases 
and ribulose bisphosphate carboxylases (54).  
 
The final step of biotin synthesis is catalyzed by BioB, biotin synthase. The 
reaction involves the insertion of a sulfur atom between the unactivated methyl and 
methylene carbon atoms adjacent to the ureido ring of dethiobiotin to form biotin. BioB 
is an iron-sulfur cluster containing homodimeric enzyme belonging to the radical SAM 
superfamily (7). Detailed mechanism involves a complex SAM-dependent radical 
chemistry that results in abstraction of the sulfur atom from its [2Fe-2S]2+ cluster (122). 
BioB was also termed a “suicide enzyme” because removal of sulfur atom from [2Fe-
2S]2+ cluster renders it inactive for the next round of catalysis (7). Since the cluster is 
buried deep in the enzyme (7), rebuilding it requires the enzyme to unfold, which exposes 
it to proteolytic degradation (14). Biotin synthase has been shown to be catalytically 
active both in vivo (15) and in vitro (35) quelling previous doubts of BioB being a 
reactant rather than an enzyme. Despite low turnovers of biotin synthase, biological 
processes can continue due to low requirement for biotin (100 molecules/cell in E. coli) 
(14).  
 
Diversity in first stage of synthesis 
The first stage of biotin synthesis was recently elucidated in E.coli by Lin and 
coworkers (1, 76, 75) after a long history of ambiguity concerning the genes and the 
intermediates involved in the pathway. In contrast to the second stage of the pathway, 
there is no conserved way to generate the pimelate thioester intermediate in microbes due 
to the range of gene diversity (Figure 1-5). Of the relatively well studied organisms, E. 
coli and B. subtilis have different sets of genes predicted for pimelate thioester 
generation: bioC and bioH in E. coli (6, 111), and bioW and bioI in B. subtilis (10). 
Several other organisms either have the same genes or bioC with bioH homologs, bioG in 
Haemophilus influenza and Campylobacter jejuni (110), bioK in Prochlorococcus 
marinus (117), bioJ in Francisella novicida (37) or bioV in Helicobacter sp. (8). On the 
other hand, close relatives of B. subtilis (B. licheniformis, B. amyloliquefaciens) possess 
both bioW and bioI. Two genes, bioW and bioX, are identified in Bacillus (now 
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Lysinibacillus) sphaericus and Staphylococcus aureus whereas Methanococcus janaschii 
and Chlamydia trachomatis have a lone bioW (110).  Another unique gene bioZ has been 
identified on the acquired symbiosis island of Mesorhizobium loti (12). Hence, it is 
possible to have multiple mechanisms at work in diverse organisms for the first stage of 
pimelate thioester intermediate synthesis. 
 
The idea of pimelate being a precursor of biotin originated after Mueller, 
duVigneaud and coworkers described its growth stimulating effect on cultures of 
Corynebacterium diphtheria in biotin-free media (24, 88). Twenty years later, multiple 
researchers demonstrated the incorporation of 14C-pimelic acid into biotin vitamers in 
Phycomyces blakesleeanus and Aspergillus niger providing the first direct evidence of 
pimelic acid as a precursor for biotin (31, 32). Subsequently, transformation of pimeloyl-
CoA to KAPA was demonstrated in cell-free extracts of E. coli (29), B. sphaericus (60) 
and several other microbes (57), providing a strong evidence for pimeloyl-CoA to be a 
likely intermediate in E. coli biotin synthesis. However, pimelic acid had no effect on E. 
coli biotin synthesis, which was speculated to be due to lack of permeability, as shown by 
the inability of E. coli to uptake 14C-pimelic acid (102).  
 
Concomitant NMR studies of 13C-labeled biotin originating from [1-13C] acetate 
or [2-13C] acetate established a model for a plausible pathway for pimeloyl-CoA 
synthesis in E. coli similar to fatty acid synthesis and polyketide synthesis (55, 113). 
Results from these studies provided evidence for a pathway previously described by 
Lezius and coworkers (74). In this pathway, the seven-carbon dicarboxylate is 
synthesized by condensing three malonyl-CoA precursors while retaining the ω-carboxyl 
group of the initial malonyl-CoA. Additionally, these experiments dictated the origin of 
all the carbon atoms of biotin and provided concrete evidence to disqualify free pimelic 
acid as a precursor for E. coli biotin synthesis. The unique labeling pattern of biotin 
obtained from [1-13C] acetate or [2-13C] acetate indicate that the two carboxyl carbons of 
pimelic acid are metabolically distinct (Figure 1-6). Hence, pimelic acid could not be a 
free molecule and had to be attached to a carrier molecule (CoA, acyl carrier protein, 
condensing enzyme) via thioester linkage before its incorporation into biotin. Sanyal and 
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coworkers also noted that the labeling pattern eliminated other probable pathways for 
pimelate/pimeloyl-CoA synthesis via oxidation of octanoate, elongation of 2-
ketoglutarate, or derivation from the tryptophan, lysine or diaminopimelate pathways 
(113). However, no concrete pathway could be determined for decades because studies 
failed to elucidate the precise function of bioC and bioH in E. coli.  
 
The BioC-BioH pathway of Escherichia coli  
It was not until 2010 when Lin and coworkers made a breakthrough on the 
detailed mechanistic roles of BioC and BioH to generate pimelate moiety by utilizing the 
existing fatty acid synthesis pathway (Figure 1-3). It was revealed through insightful 
experiments that BioC transfers a methyl group from SAM to malonyl-ACP to form 
malonyl-ACP methyl ester (76). The methyl group serves a critical purpose to protect the 
charged carboxyl end of malonyl moiety so it can be tolerated by hydrophobic active sites 
of fatty acid enzymes for two rounds of the normal reduction, dehydration, reduction 
cycle to generate pimeloyl-ACP methyl ester (75). BioC was found to prefer malonyl-
ACP over malonyl-CoA for the methyl acceptor, which changed our understanding about 
the acyl-carrier molecule for biotin synthesis in E. coli. Acyl carrier protein (ACP) and 
coenzyme A (CoA) share the phosphopantetheine group. It is esterified to an adenosine 
mono-phosphate in CoA, and in ACP the hydroxyl group of a serine residue of the 
protein is linked to the pantotheine moiety through a phosphodiester linkage (125). Being 
similar in structure, they can often be used interchangeably in in vitro enzyme assays that 
require either CoA or ACP but with different affinities (77). BioH then cleaves the 
methyl ester bond to generate pimeloyl-ACP, preventing further chain elongation (1). 
Hence, contrary to previous idea of pimeloyl-CoA being the intermediate, pimeloyl-ACP 
was revealed to be physiologically relevant intermediate in E. coli biotin synthesis. 
Organisms with the same genes or its homologs are expected to have an analogous 
pathway for the first stage of biotin synthesis.  
 
The BioW-BioI pathway of Bacillus subtilis 
The absence of genes homologous to bioC and bioH in B. subtilis and many other 
organisms indicates a departure from the above mentioned pathway for pimelate moiety 
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synthesis. Comparative genomic analyses revealed bioW as the more frequent 
replacement for bioC and bioH as opposed to bioZ, while bioI or bioX seem to 
accompany bioW in some of the genomes (110). BioW is annotated as a pimeloyl-CoA 
synthetase that catalyzes ATP-dependent transfer of pimelic acid to CoA, resulting in 
pimeloyl-CoA. Izumi and coworkers first demonstrated the formation of pimeloyl-CoA 
from pimelic acid, ATP, CoA and Mg2+ in Bacillus megaterium (61, 58), naming the 
enzyme pimeloyl-CoA synthetase. Gloeckler and coworkers characterized the bio genes 
of B. sphaericus that result in dethiobiotin from pimelate (40). Genetic complementation 
studies revealed the ability of bioW to bypass the requirement for pimelate thioester 
intermediate conferred by ∆bioC ∆bioH mutations in E. coli, when pimelic acid is 
supplied in the minimal medium. Subsequently, the enzymatic activity of B. sphaericus 
BioW was characterized and confirmed as a pimeloyl-CoA synthetase (107). Hence, 
bioW requiring organisms like B. subtilis appear to have a direct mechanism to utilize 
free pimelic acid in a one-enzyme reaction dedicated to pimelate thioester synthesis.  
 
B. subtilis represents a group of microbes that harbor two genes for the same 
function, synthesis of pimelate thioester moiety. Bower and coworkers extensively 
characterized B. subtilis bio operon with bioW and bioI in a single unidirectional operon 
along with bioA, bioF, bioD and bioB (10). Genetic deletion and complementation 
studies revealed both bioW and bioI are independently capable of bypassing the 
requirement for pimeloyl-ACP in E. coli ΔbioC and ΔbioH mutant strain. Genetic 
mutation analysis revealed that bioW is important for biotin synthesis since its mutation 
caused biotin auxotrophy, while bioI causes a bradytrophic phenotype (10). Biochemical 
data on BioI argues otherwise, suggesting that BioI is the primary enzyme responsible for 
the generation of pimeloyl-ACP. B. subtilis BioI has been extensively characterized 
compared to BioW. BioI is a cytochrome P450 with significant sequence homology and 
spectral properties characteristic of other P450s that show a spectrophotometric peak at 
450 nm when bound to carbon-monoxide in a reduced state (39, 43, 100, 119). BioI is 
one of the eight cytochrome P450s revealed to be present in B. subtilis genome (70). 
Cytochrome P450s constitute a large family of hemoproteins that are capable of 
catalyzing oxidation of a vast range of organic compounds (73, 92). The mechanism of 
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C-C bond cleavage involves activation of molecular oxygen to produce a highly reactive 
Fe (V)-oxo species from two rounds of NAD(P)H dependent flavodoxin/ferredoxin-
mediated reductions (92). B. subtilis Fer protein is believed to be the electron donor 
ferredoxin, however, the partner ferredoxin reductase has not been found (42). orf2, a 
gene downstream to bioI, has sequence similarities to putative NADH- or NADPH- 
binding sites, however, deletion of orf2 had no effect on biotin synthesis (10). 
 
Stok and coworkers purified heterologously expressed BioI bound to E. coli acyl-
ACP ranging in length from C14-C18 (119). Liberation of fatty acids from BioI-ACP 
complex under basic conditions yielded pimelic acid, albiet to a low percent, inciting the 
authors to predict BioI as a source of pimeloyl-ACP for biotin synthesis. This finding 
supported previous genetics reports of bioI mutants causing a bradytrophic phenotype 
(10). Turnover of free fatty acids to low amounts of pimelic acid by BioI was also 
detected.  Green and coworkers demonstrated a mechanism of cleaving free fatty acid via 
ω-hydroxylation followed by chain shortening reactions to produce pimelic acid (43). 
Later, high resolution crystal structure of BioI-acyl-ACP complex revealed a 
hydrophobic binding pocket above the active-site heme iron, where the incoming fatty 
acid chain adopts a kinked U-shaped conformation (19). The precise placement of C7 and 
C8 atoms above the heme iron independent of fatty acid chain length clearly indicated C-
C cleavage that results in pimeloyl-ACP by three rounds of oxidations (119). The 
specificity of BioI catalytic activity was attributed to ACP protein being bound to the 
fatty acids in absence of which an assortment of products of different chain lengths are 
generated (19, 119). Hence, biochemical studies suggest that BioI contributes to the 
biotin biosynthetic pathway by generating pimeloyl-ACP whereas pimelic acid might be 
a byproduct of BioI catalytic activity, which is yet to be examined. 
 
B. subtilis therefore seemed to have a redundant system in the first stage of the 
pathway (Figure 1-4). It needed to be determined whether BioI and BioW function in 
conjunction or independently. It is logical to postulate that BioI can generate a pimelate 
thioester moiety independent of BioW to produce biotin, serving as a salvage pathway 
rather than an obligatory pathway.  Since deletion of bioW conferred a more deleterious 
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effect on growth, BioW could be the essential enzyme involved in the generation of 
pimelate thioester from pimelic acid possibly via BioI or some other unknown source. 
The pathway for synthesis of pimelic acid is undetermined. Previous studies have 
reported the formation of pimelic acid as a by-product of azelaic acid degradation in yeast 
(97) Pseudomonas sp. (62) and Micrococcous sp. (95). Pimelic acid has also been shown 
to be synthesized from C18 fatty acids such as exogenously supplemented oleic acid 
(18:1 cis-9), thought to be the precursor of azelaic acid (nine carbon α, ω-dicarboxylic 
acid), and linoleic acid (18:2 cis, cis-9,12) in various bacteria (98, 99). However, unlike 
most living organisms that have straight-chain acids with or without unsaturation in the 
carbon chain, B. subtilis has major amounts of lipids made of rare branched-chain fatty 
acids having a methyl group at the iso or anteiso positions (66). This adds to the 
conundrum for the synthesis of pimelate, a seven-carbon straight chain dicarboxylate.  
 
The redundancy in pimelate thioester generation also raises an important question 
about the substrate specificity of BioF, the next enzyme that utilizes the pimelate 
thioester intermediate to make KAPA. Since there are two derivatives of pimelate moiety 
available, does it accept both or prefer one over the other for KAPA synthesis? B. subtilis 
BioF has 50% amino acid sequence identity to the BioF of B. sphaericus which has been 
well characterized for its synthesis of KAPA from pimeloyl-CoA (106, 105). E. coli 
BioF, however, was reported to have a lower affinity for pimeloyl-CoA compared to that 
of B. sphaericus (128). Since pimeloyl-ACP is the intermediate in E. coli, I hypothesize 
E. coli BioF to have higher affinity with pimeloyl-ACP compared to the CoA moiety 
which is the only pimelate derivative tested so far. Hence, E. coli and B. subtilis BioF 
may be diverse in their specificity for different pimelate thioester moieties because of the 
difference in how the intermediates are synthesized. Therefore, determining the substrate 
specificity of B. subtilis BioF will help elucidate the physiologically relevant carrier 
molecule of pimelate and also help resolve the question about the redundancy of 
BioW/BioI pathway. 
 
The existence of two pathways to generate pimelate thioester in B. subtilis is 
unusual. Speculations can be made about the reason as to why the organism has two 
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enzymes, possibly for the same purpose. I hypothesize that BioW is the important 
enzyme to generate pimeloyl-CoA while BioI is dispensable for biotin synthesis. This is 
based on the evidence that the gene bioI has not been found to exist in an operon without 
bioW. Only B. subtilis and a few close relatives have genes that are identified as bioI. 
However, bioW has been found in a diverse range of organisms as a sole provider of 
pimelate thioester moiety (110). Furthermore, bioI is the last gene in the bio operon with 
a preceding putative terminator and is transcribed 8-fold lower than the rest of the operon 
upstream to it (104). BioI might be an evolutionary remnant when B. subtilis and its close 
relatives were strict aerobes depending on a cytochrome P450 enzyme for the synthesis 
of biotin. B. subtilis is a soil bacterium and it might have acquired the new gene bioW to 
learn to adapt to different oxygen levels present in soil hence, increasing its chances of 
survival. Indeed, B. subtilis was regarded as a strict aerobe until a review by Priest 
mentioned its ability to grow slowly under strictly anaerobic conditions with nitrate as 
terminal electron acceptor (93, 109).  
 
SPECIFIC AIMS OF THIS THESIS 
 
I started to work on this Thesis project to answer three major questions about 
biotin synthesis in B. subtilis: the redundancy of pimelate thioester generation, origin of 
pimelic acid and the substrate specificity of BioF. In the following chapters, I have 
described the approaches taken to answer these long-standing questions.  
 
In Chapter 2, I characterized the enzymatic properties of BioW to provide 
evidence for its pimeloyl-CoA synthetase function. BioW is a unique enzyme belonging 
to a pimeloyl-CoA synthetase family that is different from any other acyl-CoA synthetase 
known in terms of sequence and structure. I describe a unique characteristic of B. subtilis 
BioW to proofread non-cognate acyl-adenylate intermediates, a characteristic similar to 
the editing function of amino-acyl tRNA synthetases. The reaction of pimeloyl-CoA 
synthesis is a two-step process that involves the formation of an acyl-adenylate 
intermediate, which is transformed into acyl-CoA. I found that BioW is able to proofread 
glutaryl- (five carbon) and suberyl-(eight carbon) adenylate and thus, prevents the 
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synthesis of shorter and longer chain acyl-CoA for biotin synthesis. Recently, a 
collaboration with Dr. Satish Nair resulted in the first crystal structure of BioW from 
Aquifex aeolicus which provided insights on what residues might be involved in the 
binding and proofreading functions of the enzyme.  
 
In Chapter 3, I demonstrate the significance of BioW as the sole producer of 
pimelate thioester intermediate for B. subtilis biotin synthesis. BioI is capable of 
generating pimeloyl-ACP. However, this function seems to be wasteful in B. subtilis 
since absence of bioI (gene mutation) and growth in anaerobic condition (inactive bioI) 
does not affect biotin synthesis in minimal media. Moreover, I made advances toward 
elucidating the source of pimelic acid in vivo. In 13C-NMR experiments similar to Sanyal 
and coworkers, I provide the first evidence for pimelic acid being a bona fide precursor of 
biotin. I discovered evidence for pimelate synthesis via head-to-tail chain elongation 
process similar to fatty acid synthesis, which is supported by the negative effects of fatty 
acid inhibitors on biotin synthesis in vivo.  
 
In Chapter 4, I summarize all my findings to provide a better understanding about 
the biotin synthetic pathway in B. subtilis and other organisms that are pertinent to this 
study.  
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FIGURES 
 
 
Figure 1.1: A) Structure of biotin. It consists of an ureido ring and a tetrahydrothiophene 
ring attached to a valeric acid side chain. B) Function of biotin. Biotin attaches to the 
BCCP subunit of biotin dependent enzymes forming an amide bond with a conserved 
lysine residue. Biotin is carboxylated in an ATP-dependent manner by biotin carboxylase 
using bicarbonate as a source of CO2. It acts as a swinging arm and travels to the 
carboxyl transferase subunit, where the carboxyl group is transferred from biotin to 
acetyl-CoA to generate malonyl-CoA, in case of acetyl-CoA carboxylase.  
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Figure 1.2: The biotin biosynthesis pathway in B. subtilis. It can be separated into two 
distinct stages. First stage represents two possible pathways to synthesize pimelate 
thioester intermediate via either BioW (pimeloyl-CoA synthetase) or BioI (a cytochrome 
P450). Pimelate thioester may be in the form of pimeloyl-CoA or pimeloyl-ACP. The 
second stage of the pathway involves BioF driven synthesis of 8-amino-7-oxo-nonanoate 
(AON) which is converted to 7, 8-diamino-nonanoate (DAN) by BioA. BioD transforms 
DAN into dethiobiotin (DTB) which is finally converted to biotin by BioB. Biotin is 
attached to a conserved lysine residue of a biotin dependent enzyme in an ATP dependent 
manner. After attachment, biotin is carboxylated on N1. Abbreviations: SAM, S-
adenosyl-L-methionine; 5’-DOA, 5’-deoxyadenosine; ATP, Adenosine -5`-triphosphate. 
This figure is adapted from a review by Lin et al (77). 
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Figure 1.3: The initial stage of biotin synthesis in E. coli via BioC and BioH. BioC 
catalyzes the SAM-dependent transfer of methyl-group to malonyl-ACP to produce 
malonyl-ACP methyl ester. The chain elongated from three carbons of malonyl moiety 
into seven carbons of pimeloyl moiety in two rounds of reduction, dehydration and 
reduction by fatty acid enzymes to generate pimeloyl-ACP methyl ester. At this point, 
further chain elongation is halted by BioH by removing the methyl-group from the 
pimeloyl moiety. Pimeloyl-ACP is then converted to biotin by the second stage of the 
pathway that involves BioF, BioA, BioD and BioB. Abbreviation: SAH, S-
adenosylhomocysteine. This figure is adapted from Lin et al (75). 
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Figure 1.4: Schematic representation of three possible pathways for pimelate thioester 
synthesis via BioI and BioW. In the first pathway, BioI generates pimeloyl-ACP from C-
C bond cleavage of long chain acyl-ACP. In the second pathway, BioI provides pimelic 
acid via C-C bond cleavage of free fatty acids and BioW synthesized pimeloyl-CoA. In 
the third pathway, BioW acquires pimelic acid from a yet unknown synthesis pathway(s) 
to produce pimeloyl-CoA. Finally, it is upon BioF to decide which intermediate to use, 
pimeloyl-ACP or pimeloyl-CoA for the completion of biotin synthesis.  
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Figure 1.5: Diversity of gene arrangement in bio operon. The genes involved in the 
initial stage of biotin synthesis are represented in bold font. Diverse organisms like E. 
coli and B. cereus contain both bioC and bioH. bioH is replaced by its homologs bioG, 
bioK and bioJ in H. influenzae, P. marinus  and F. novicida respectively. S. aureus and B. 
subtilis contain bioW and bioX or bioI that share no sequence homology to bioC or bioH. 
Rhizobia like M. loti contain bioZ which differs from both bioW and bioC/bioH.  
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Figure 1.6: Biotin labeling patterns originating from [1-13C] or [2-13C] acetate. A) 
Schematic representation of 13C-NMR results obtained by Sanyal et al and Ifuku et al in 
E. coli. Carbons 2,4 and 6 were labeled in biotin originating from [2-13C] acetate while 
carbons 3,5 and 7 were labeled in biotin originating from [1-13C] acetate. This labeling 
pattern requires pimelate moiety to be attached at one end to a carrier molecule. B) 
Hypothetical representation of 13C-labeled biotin in B. subtilis to show that pimelic acid 
is a bona fide precursor of biotin synthesis. Unlike in E. coli, the symmetrical pimelic 
acid molecule can be incorporated in either direction to have both the carboxyl terminals 
of biotin labeled to the same extent. 
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CHAPTER 2 
PROOFREADING OF NONCOGNATE ACYL ADENYLATES BY AN 
ACYL-COENZYME A LIGASE 
 
INTRODUCTION 
 
A major determinant of the low error rate of protein synthesis is the specific 
aminoacyl-tRNA synthetase-catalyzed acylation of tRNAs by only the cognate amino 
acid.  Aminoacyl-tRNA synthetases can ensure faithful protein synthesis by having high 
substrate selectivity.  However, as first pointed out by Pauling (103), small differences in 
binding energy between aliphatic amino acids cannot provide the discrimination 
necessary for faithful protein synthesis. For amino acids having closely related structures 
such as isoleucine and valine, discrimination against the smaller amino acid would be 
incomplete.  Indeed, Baldwin and Berg (4) showed that isoleucine tRNA synthetase 
converted both isoleucine and valine to their adenylates.  However, only isoleucine was 
transferred to tRNA because valyl-adenylate was hydrolyzed to AMP and valine.  These 
acyl-adenylate editing reactions proceed either by eviction of the non-cognate acyl-
adenylate into solution where it undergoes spontaneous hydrolysis or by catalyzed 
hydrolysis within the active site (or in a separate editing site).  In some cases enzymatic 
hydrolysis is stimulated by the presence of an acceptor tRNA.  These reactions are 
generally referred to as editing, but proofreading is more accurate because proofreading 
only eliminates errors whereas editing improves the product. 
 
I report proofreading by an acyl-Coenzyme A (CoA) synthetase/ligase (synthetase 
and ligase are approved synonyms).  The acyl-CoA ligase is BioW, an enzyme required 
for biotin synthesis in Bacillus subtilis and closely related bacteria (10).  The 
physiological reaction of BioW is the ATP-dependent conversion of pimelate, a seven 
carbon α, ω-dicarboxylic acid, to its CoA monothioester (Figure 2-1A). Although BioW 
contains none of the sequence motifs characteristic of acyl-CoA ligases, the reaction was 
demonstrated to proceed through the canonical acyl-adenylate intermediate.  However, 
when presented with glutaric acid, the C5 homologue of pimelic acid, only traces of 
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adenylate and CoA thioester were formed, and much of the ATP was converted to AMP.  
Conversion of ATP to AMP in the absence of final product synthesis is the hallmark of 
pretransfer editing in protein synthesis (130).   My data argue that most of the glutaryl-
adenylate intermediate is largely cleaved within the BioW active site.   A similar, but less 
efficient, proofreading of the adenylate of a second incorrect substrate, the C8 α, ω-
dicarboxylic acid, suberic acid, also occurred. 
 
Pimelic acid (heptanedioic acid) is a seven-carbon α, ω-dicarboxylic acid that 
contributes most of the carbon atoms of biotin, the others coming from alanine and CO2  
(77) (Figure 2-1A). To be used as a biotin precursor one of the pimelate carboxyl groups 
must be activated by conversion to a thioester (of either CoA or acyl carrier protein) 
(Figure 2-1A). This thioester then reacts with alanine in the decarboxylative condensation 
reaction catalyzed by BioF to form 8-amino-7-oxononanoate, the first intermediate in 
formation of the fused heterocyclic rings of biotin (Figure 2-1A).   
 
MATERIALS AND METHODS 
 
Bacterial strains and plasmids 
The bioW gene was PCR amplified from Bacillus subtilis subsp. subtilis str. 168 
genomic DNA using primers pMM1 5`-GGA GAT ATA CCA TGA TGC AAG AAG 
AAA C-3` and pMM2 5`-CTT CTT GCA TCA TGG TAT ATC TCC TTC-3` and Pfu 
Turbo DNA polymerase from Stratagene. The amplified gene was digested with 
restriction enzymes, NcoI and XhoI, and inserted between the NcoI and XhoI sites of 
vector pET28b (Novagen). The sequence verified plasmid (pMM8) was transformed into 
E. coli BL21 Tuner (Novagen) and the transformants were plated on LB medium (per 
liter, 10 g of tryptone, 5 g of yeast extract, and 5 g of NaCl) containing 50 µg/ml of 
kanamycin sulfate. 
 
Expression and purification of BioW 
A 2 L LB culture of E. coli BL21 Tuner transformed with plasmid pMM8 was 
grown to an optical density 600 of 0.6 at 37°C followed by induction with 1 mM 
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isopropyl-β-D-thiogalactopyranoside for 5 hr at 37°C. The cells were harvested by 
centrifugation and resuspended in 50 mM Tris-HCl (pH 7.5), 100 mM NaCl, 10% 
glycerol and 5 mM tris (2-carboxyethyl) phosphine hydrochloride (TCEP), and then they 
were lysed by passage through a French pressure cell. The supernatant obtained after 
centrifugation of cell lysate at 39,000xg for 30 min at 4°C, was applied to a 5 ml HiTrap 
Q FF ion exchange chromatography column (GE Healthcare) equilibrated with the buffer 
used to suspend the harvested cells. The column was washed with 50 mM Tris-HCl (pH 
7.5), 1 M NaCl, 10% glycerol and 5 mM TCEP.  The protein fraction eluted at about 250 
mM NaCl and was analyzed by SDS/PAGE. Fractions containing the highly purified 
protein were pooled, concentrated and resuspended in 50 mM Tris (pH 7.5), 100 mM 
NaCl, 10% glycerol, 5 mM TCEP and 1 M ammonium sulfate and applied to a 5 mL 
HiTrap Phenyl HP hydrophobic interaction chromatography column (GE Healthcare) 
equilibrated with the same buffer. The column was washed with 50 mM Tris-HCl (pH 
7.5), 100 mM NaCl, 10% glycerol and 5 mM TCEP, and the protein was eluted with a 
linear gradient from 1 M to 0 ammonium sulfate. After analyzing samples by 
SDS/PAGE, the fractions having the highest degree of purity were pooled and applied to 
a HiLoad 26/60 Superdex 200 size exclusion chromatography column.  The column was 
equilibrated with 50 mM Tris-HCl (pH 8.0) containing 150 mM NaCl and the protein 
was allowed to elute over one column volume. The protein fractions of greatest purity 
were pooled and dialyzed against a storage buffer of 50 mM Tris-HCl (pH 8), 150 mM 
NaCl, 20% glycerol and 5 mM TCEP. Finally, the dialyzed protein was concentrated to 
2.7 mg/mL, flash frozen and stored at -80°C. 
 
High Performance Liquid Chromatography (HPLC) enzyme assays 
Pimeloyl-CoA ligase activity was assayed by detection of pimeloyl-CoA 
formation. The reactions contained 100 mM sodium HEPES (pH 7) buffer, 10 mM 
MgCl2, 0.1M NaCl, 0.2 mM TCEP, 5 mM pimelate, 1 mM CoA and 1 mM ATP and 
were initiated by adding enzyme to 5 µM (all enzyme concentrations are given as 
monomeric protein). After incubation at 37oC for 1 h, the reaction was stopped by adding 
10% trichloroacetic acid to precipitate the protein. The precipitated protein sample was 
removed by centrifugation and filtration through Amicon Ultra 3K devices (Millipore). 
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The filtrate was loaded onto a µBondapak C18 cartridge (Waters) previously equilibrated 
with 50 mM ammonium acetate (pH 5). Solvent A was 50 mM ammonium acetate (pH 5) 
and solvent B was acetonitrile. The sample was eluted with 0% B for 10 min, 30 min of a 
gradient from 0%B to 50% B followed by 5 min gradient from 50% B to 80% B which 
was maintained for 10 min (56). Eluent corresponding to the pimeloyl-CoA peak was 
dried under nitrogen and the mass was analyzed at the University of Illinois, School of 
Chemical Sciences Mass Spectrometry Laboratory by electrospray ionization mass 
spectrometry performed on a Micromass Q-Tof Ultima instrument run in the positive 
mode. 
 
Thin layer chromatographic enzyme assays 
 In general, the reactions contained 100 mM sodium HEPES (pH 7) buffer, 5-10 
mM MgCl2, 0.1-0.2M NaCl, 0.2 mM TCEP, 1-10 mM pimelate, 0.25 mM CoA, 25-100 
µM ATP with [α-32P]ATP 600 to 1200-fold lower in concentration than the 
nonradioactive ATP and 5 µM BioW, except where indicated.  The specificity of BioW 
was tested with malonic acid (C3), succinic acid (C4), glutaric acid (C5), adipic acid 
(C6), pimelic acid (C7), suberic acid (C8), azelaic acid (C9). To assay non-cognate 
substrate editing by BioW, the rate the AMP formation in the absence of CoA was 
monitored in a time dependent manner. At each time point 1 µl of the reaction was 
spotted onto a thin-layer plate. Kinetic parameters for pimelate and CoA were determined 
by varying the concentration (5-100 µM) of the respective substrate in a reaction 
containing 50 nM BioW in order to achieve a linear progression of enzymatic activity. 
Thin-layer chromatography (TLC) on cellulose plates was developed in isobutyric acid: 
ammonium hydroxide: water (66:1:33) (16). After drying, the thin layer chromatograms 
were exposed to a phosphor imaging plate for 1-17 hr and the results visualized using a 
Fujifilm FLA-3000 instrument. The chromatogram spots were quantitated by comparing 
them with a standard curve generated by serial dilution of known [α-32P]ATP 
concentration for each plate. All reactions were repeated three times and the kinetic 
parameters were determined by fitting the data points to Lineweaver-Burk plots. 
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RESULTS AND DISCUSSION 
 
Although in Escherichia coli pimelate is formed by a modified fatty acid synthetic 
pathway (75), the source of pimelate in B. subtilis remains unknown.  However, the role 
of BioW is clear; strains lacking BioW are defective in biotin synthesis (see Chapter 3).  
Moreover, upon expression of BioW in E. coli, pimelate supplementation allows bypass 
of mutations in pimelate synthesis (10, 75). BioW is an extremely unusual acyl-CoA 
ligase in that it lacks all of the well-characterized motifs of this highly conserved enzyme 
family (45) and is half the typical size.  This remarkable divergence from the canonical 
enzymes led us to purify BioW and characterize the pimeloyl-CoA synthesis reaction in 
detail.  
 
Attachment of hexahistidine tags to either end of BioW destroyed the ability of 
the protein to function in E. coli; thus, the enzyme was purified by conventional column 
chromatography steps to obtain preparations that gave a single band in denaturing gel 
electrophoresis and a single peak on size exclusion chromatography that indicated BioW 
is a dimeric protein (Figures 2-4 and 2-5).  Pimeloyl-CoA synthesis was assayed by high-
pressure liquid chromatography (HPLC) with detection by UV absorbance, and required 
pimelate, ATP, Mg2+ and CoA (Fig.  1b). Pimeloyl-CoA formation, verified by mass 
spectroscopy (Figure 2-1D), was accompanied by production of AMP consistent with a 
pimeloyl-adenylate intermediate.  Use of [α-32P]ATP allowed direct demonstration of the 
pimeloyl-adenylate intermediate that accumulated in the absence of the CoA acceptor and 
was converted to AMP upon addition of CoA (Figure 2-1C).  The overall reaction had the 
stoichiometry expected of an acyl-CoA ligase; one pimeloyl-CoA molecule was formed 
per ATP hydrolyzed to AMP (45).  The reaction was most rapid at pH 7.  ATP was the 
sole active nucleotide triphosphate and a metal ion (Mg2+ > Mn2+ > Co2+) was required. 
(Figure 2-6). In addition, the kinetic parameters for pimelate and CoA were determined in 
sodium 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer at pH 7 
using the α-32P-labeled ATP assay (Figure 2-1B). These data showed that BioW is a 
notably poor catalyst.  This property is characteristic of biotin synthetic enzymes (5, 77, 
75) consistent with the extremely low physiological demand for biotin.   
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The BioW dicarboxylate substrate specificity was first determined in the overall 
reaction, and as expected, pimelate was the best substrate (Figures 2-1A & 2-2B).  No 
synthesis of the CoA ester was seen with the C6 homolog adipic acid, whereas the C8 
acid suberic acid was only weakly active, verified by ESI-MS (Figure 2-7), and the C5 
acid glutaric acid gave only traces of the CoA ester (Figure 2-2B). To determine which 
partial reaction limited use of the noncognate substrates, α-32P-labeled ATP was used to 
assay conversion of the acids to their acyl-adenylates in the absence of CoA.  Adipic (C6) 
and suberic (C8) acids synthesized detectable levels of their adenylates, whereas the C5 
homolog glutaric acid formed only trace amounts of glutaryl-adenylate (Figure 2-2C). 
However, in the glutarate reactions AMP accumulated at the expense of ATP in a 
glutarate-dependent manner (Figure 2-2C). AMP accumulation in reactions with a 
noncognate substrate is the hallmark of pretransfer proofreading (editing) by aminoacyl-
tRNA synthetases; the adenylate is synthesized and then cleaved to AMP (85, 130).  For 
some aminoacyl-tRNA synthetases, proofreading is largely or totally dependent on the 
presence of the tRNA cognate to the synthetase (130).  However, the presence of CoA 
had no detectable effect on glutaryl-adenylate hydrolysis by BioW (Figure 2-2C).  Note 
that the low levels of glutaryl-CoA accumulation cannot be attributed to solvent 
hydrolysis of the thioester. Glutaryl-CoA is a well-studied enzyme substrate and is not an 
unusually labile acyl-CoA.  Indeed, I monitored the thioester linkage by absorbance at 
232 nm of a solution of glutaryl-CoA at 23oC for 3 hr in assay buffer at pH 7.5 without 
detectable loss of absorbance.    
 
The C8-adenylate also showed signs of hydrolysis to AMP, whereas the C6-
adenylate accumulated but showed no hydrolysis in the absence of CoA (Figure 2-2C).  
Upon CoA addition AMP levels increased somewhat, but no adipoyl-CoA was formed 
(Figure 2-2B), suggesting that CoA increased solvent hydrolysis of the enzyme-bound 
C6-adenylate.  The BioW reaction with adipic acid (C6) was not further studied because 
it is not a naturally occurring compound and thus physiologically irrelevant.  
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As reported for aminoacyl-tRNA synthetase pretransfer editing reactions (130), 
adenylate hydrolysis could occur either by cleavage within the BioW active site or by 
release of the adenylate to solution where the mixed anhydride bond would be cleaved by 
hydroxide ion. The rate of acyl-adenylate hydrolysis increases as pH values rise above 
neutrality (21, 64, 114); thus, hydrolysis of adenylates released to solution should 
increase with pH.  However, in the C5- and C8-adenylates, increased solvent pH had no 
effect on hydrolysis of the adenylate (Figure 2-3A). The most straightforward 
interpretation of these data is that these adenylates are largely sequestered within the 
BioW active site.  If so, then hydrolysis of the C5- and C8-adenylates must proceed 
within the enzyme active site.  In contrast, the level of the C7-adenylate declined at 
elevated pH values with a concomitant increase in AMP, indicating that solvent could 
access this adenylate (Figure 2-3A).  A greater accessibility of C7-adenylate bound 
within the active site seems reasonable because the CoA thiol must enter the active site 
for pimeloyl-CoA production.  However, a pH-induced conformational change that 
releases the C7-adenylate to solution could also occur.  The BioW-catalyzed hydrolysis 
of the C5- and C8-adenylates was linear with time, whereas pimeloyl-adenylate filled the 
BioW active site (one molecule of pimeloyl-AMP per BioW monomer) whereupon AMP 
production essentially ceased (Figure 2-3C).  
 
BioW proofreading by cleavage of glutaryl-adenylate is reminiscent of valine 
activation by isoleucine-tRNA synthetase, a situation first addressed by Pauling (103) 
who calculated that the small differences in binding energy among aliphatic amino acids 
could not provide the discrimination necessary for accurate protein synthesis.  He 
estimated that incorporation of isoleucine would be favored over valine by a factor of 
only 100-200.  Direct binding measurements to isoleucyl-tRNA synthetase confirmed 
Pauling’s prediction (78).  However, the error rate in insertion of valine for isoleucine is 
1 in 3,000 (79) due to proofreading (38). Pauling’s argument also pertains to the BioW 
reaction with glutarate.  Glutarate is smaller than pimelate, precluding steric occlusion, 
and the two additional methylene groups of pimelate would not provide sufficient binding 
energy to insure specificity.  Moreover, glutaric acid occurs in nature and is particularly 
abundant in seeds and root vegetables.  Thus, it seems likely that B. subtilis, a soil 
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bacterium, could encounter high levels of this dicarboxylate and that proofreading of the 
adenylate would act to prevent possible short circuiting of biotin synthesis by glutarate. 
 
Suberic acid also occurs naturally; thus, hydrolytic proofreading of its adenylate is 
appropriate.  Superficially, isoleucine activation by valine-tRNA synthetase would seem 
an appropriate comparison, because the noncognate substrate has one additional 
methylene group.  However, the chiral amino acid must bind the enzyme with strict 
stereochemistry, whereas the nonchiral and flexible dicarboxylate is able to bind in a 
manner that allows formation of the adenylate and low levels of the CoA ester. 
 
The broad question is whether or not BioW proofreading has an evolutionary 
relationship with aminoacyl-tRNA synthetase pretransfer editing.  This may be the case, 
but the extant protein sequences provide no support for a relationship.  BioW is a most 
unusual protein in that database searches by a large number of search algorithms, 
including those designed to detect very remotely homologous sequences (e.g., HMMER 
http://hmmer.janelia.org/), give only BioW sequences.  Moreover, as mentioned above, 
BioW has no recognized sequence motifs.  This is not surprising for pimelate, an unusual 
ligand, but it is surprising for CoA and especially so for ATP.  There may be structural 
homologies that could speak for (or against) a relationship between BioW and aminoacyl-
tRNA synthetases, but this will require a BioW crystal structure.   
 
Other examples of hydrolytic proofreading are known, although they involve 
different chemistry.  For example, in polyketide synthesis a report demonstrated that a 
protein previously thought to be an acyltransferase was a thioesterase that specifically 
cleaved noncognate acyl-thioesters (64).  It seems reasonable that proofreading reactions 
may occur most often in the early steps in synthesis of complex molecules such as biotin 
or an intricate polyketide to prevent embarking on the expensive synthesis of inactive 
molecules.   
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FIGURES 
 
 
Figure 2.1: Schematic of B. subtilis biotin biosynthesis and the BioW reaction.  
A) The pathway begins with the conversion of pimelate to pimeloyl-CoA by an ATP-
dependent reaction catalyzed by BioW, with the adenylate as intermediate. The pimelate 
thioester provides most the carbon atoms of the biotin, as indicated in red. The pimelate 
thioester reacts with L-alanine in a decarboxylative condensation catalyzed by BioF to 
form 8-amino-7-oxononanoate, the first intermediate in formation of the fused 
heterocyclic rings of biotin. Ring formation is completed by successive reactions 
catalyzed by BioA, BioD and BioB to generate biotin. B) The BioW reaction with 
pimelate as substrate with separation of substrates and products by reverse-phase HPLC. 
The absorbance peaks were identified using authentic standards of ATP, AMP and CoA. 
Below the chromatogram the steady state kinetic parameters for pimelate and CoA 
determined in sodium HEPES buffer (pH 7) with 50 nM BioW are given. The parameters 
were determined by fitting the data from three independent experiments to Lineweaver-
Burk plots and are given as the mean ± SE. C) Thin layer chromatography of [α-
32P]ATP-labeled reactions in the absence and presence of CoA. A time course is shown 
for the CoA reactions. D) Identification of pimeloyl-CoA (calculated mass 910.18) by 
electrospray ionization mass spectroscopy.  The sharp peak eluting after 31 min in B) was 
collected, dried under nitrogen and submitted for mass spectroscopy.  
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Figure 2.2: Dicarboxylate specificity of BioW. A) BioW reactions were performed with 
dicarboxylic acids from C3 to C9 to determine acyl chain substrate specificity. The 
reactions were carried out as described in Methods and Materials, and 1 µl of each 
reaction was spotted onto cellulose TLC plate. B) CoA thioester formation from the C5, 
C6 and C8 dicarboxylates after reaction with BioW at 37°C for 1 hr. Panels from top to 
bottom show HPLC analyses of BioW reactions with the C5, C6 and C8 dicarboxylates, 
respectively. C) Evidence of adenylate editing in absence of CoA. BioW reactions with 
the C5, C6, C7 and C8 dicarboxylates were carried out in presence or absence of CoA at 
37°C for 1 h. Samples of 1 µl were spotted onto a TLC plate which was developed as 
described in Methods and Materials.  Note that the migration rates of the acyl-AMP 
intermediates vary with the dicarboxylate moiety. C8-CoA was identified by mass 
spectroscopy (Figure 2-7) whereas the trace amounts of C5-CoA formed were 
insufficient for analysis. 
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Figure 2.3: Cleavage of cognate and noncognate adenylates. A) The pH profiles of BioW 
activity with pimelate (top), glutarate (middle) and suberate (bottom) in absence of CoA. 
Buffers of sodium acetate (pH 4 and pH 5), sodium 2-(N-morpholino)ethanesulfonic acid 
(pH 6), sodium HEPES (pH 7) and Tris-HCl (pH 8 and pH 9) were used to determine the 
pH profile of the BioW reaction for 1 h at 37 ̊ C. B) BioW catalyzed glutaryl- and 
suberyl-adenylate hydrolysis was assayed by determining the rate of AMP production 
with time. Reactions with pimelate (C7) were included for comparison. At different time 
points 1 µl samples of BioW reactions performed at pH 7.0 and 37 ̊ C were spotted onto 
cellulose TLC plates followed by development and autoradiography. C) Quantitation of 
the data points in B) were used to show the rate of formation of AMP with increasing 
time with C7, C5 and C8 as substrates. The intensities of the spots were quantitated using 
the phosphor-imaging software of the Fujifilm FLA-3000 phosphorimager. The percent 
of photostimulated luminescence of AMP and acyl-AMP spots obtained from the reaction 
was compared to that of the ATP spot obtained from a control reaction lacking enzyme 
on each cellulose TLC plate to derive the amounts of products generated. All reactions 
were repeated three times, and the data are represented as SEs. 
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Figure 2.4: Three step purification of native B. subtilis BioW. A) Ion exchange 
chromatography using a HiTrap Q FF column. B) Hydrophobic interaction 
chromatography using HiTrap Phenyl HP column; C) Preparative size exclusion 
chromatography using HiLoad Superdex 200 column. D) 12% SDS-PAGE showing 
purity of BioW (29.7 kDa) in the three successive chromatographic steps denoted by A, B 
and C, respectively. M, molecular weight markers in kDa; lane 1, sample of uninduced 
culture; lane 2, sample of induced culture; lane 3, crude lysate; lane 4, supernatant; lane 
5, flow-through of the ion exchange column.  
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Figure 2.5: BioW solution structure. A) BioW (lower panel) eluted between bovine γ-
globulin (a, 158 kDa) and chicken ovalbumin (b, 44 kDa) (upper panel) from an 
analytical Superdex 200 column, indicating that it is a dimeric protein. B) Chemical 
cross-linking of purified BioW (20 µM) with increasing concentrations (0, 0.005, 0.01, 
0.05, 0.1, 0.5, 1 and 5 mM) of ethylene glycol bis-succinimidylsuccinate (EGS) shows a 
BioW dimer between 50 kDa and 75 kDa. The purified protein was incubated with EGS 
for 30 min at room temperature and the result was analyzed by 12% SDS-PAGE. M, 
protein molecular weight standards. 
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Figure 2.6: Nucleotide triphosphate and metal ion specificities of B. subtilis BioW. 
HPLC analysis of reaction of BioW with various nucleotide triphosphates. A) CTP, B) 
GTP and C) UTP. All panels show the CoA peak and a peak corresponding to the 
nucleotide triphosphate. The reaction and samples were handled as described in Methods 
and Materials. D), Metal ion dependence in reactions containing either a metal ion at 5 
mM or 5 mM EDTA in a buffered solution of pH 7.  All metal ions were added as the 
chlorides. The error bars represent standard deviations. 
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Figure 2.7: Identification of suberyl-CoA (calculated mass 924.2) by electrospray 
ionization mass spectroscopy. The analysis was performed as described in Methods and 
Materials on the HPLC peak of Figure 2-2B (C8-CoA). The peaks at higher mass are 
probably metal ion adducts of the acidic CoA moiety. 
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CHAPTER 3 
PIMELIC ACID, THE FIRST PRECURSOR OF THE BACILLUS 
SUBTILIS BIOTIN SYNTHESIS PATHWAY, EXISTS AS THE FREE ACID AND 
IS ASSEMBLED BY FATTY ACID SYNTHESIS 
 
INTRODUCTION 
 
The initial stage of biotin synthesis pathway varies widely depending on the 
enzymes responsible for synthesis of a thioester of pimelic acid, a seven carbon α, ω-
dicarboxylic acid (IUPAC name, heptanedioic acid). The role of this unusual molecule as 
a biotin precursor was discovered many years ago as a compound that bypassed the biotin 
requirement for growth of Corynebacterium diphtheriae (91, 90, 89). Later work showed 
that pimelic acid supplementation bypassed the biotin requirements of a subset of 
naturally biotin-requiring bacteria and fungi. Conversion of 14C-pimelic acid into biotin 
and synthesis of biotin vitamers from pimelic acid in cell-free extracts of various bacteria 
indicated that pimelate was a direct precursor of biotin (58) and was probably 
incorporated intact eisenberg incorp (31). Seminal in vitro studies by Eisenberg and 
coworkers (30, 29)  demonstrated that E. coli extracts could condense pimeloyl-CoA with 
alanine to give the first intermediate in biotin ring formation and that BioF catalyzed this 
reaction.  However, the source of pimelate and the identity of its thioester derivative in E. 
coli remained unknown (the high pimeloyl-CoA concentrations required suggested it may 
not be the physiological thioester).  
 
Recent work from this laboratory showed that synthesis of the acyl carrier protein 
(ACP) thioester of pimelate (pimeloyl-ACP) proceeds by a modified fatty acid synthesis 
pathway(1, 76, 75). Pimeloyl-ACP then reacts with alanine in the BioF reaction to give 8-
amino-7-oxononanoate. Although many bacteria use the BioC-BioH pathway (or 
variations in which other esterases replace BioH), there are biotin prototrophic bacteria 
that lack BioC encoding genes and a known esterase able to cleave pimeloyl-ACP methyl 
ester. In this regard the most puzzling of these are the Bacilli. The bio operons of B. 
subtilis and closely related bacilli (e.g. B. licheniformis, B. amyloliquefaciens, etc.) lack 
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bioC and bioH and instead have bioW and bioI.  In contrast B. cereus and closely related 
bacteria (e.g., B. anthracis, B. thuringiensis, etc.) encode BioC and BioH proteins within 
their biotin operons that are quite similar and can functionally replace the E. coli proteins.  
 
 The B. subtilis bioW and bioI genes are, respectively, the first and last genes of 
the biotin operon (10) (Figure 3-1).  The intervening genes, bioAFDB, are readily 
identified due to the strong conservation of their protein sequences across diverse bacteria 
and fungi.  B. subtilis BioW has long been known to be a pimeloyl-CoA synthetase (10, 
107)  and this atypical acyl-CoA synthetase has been studied in detail in recent enzyme 
mechanism and x-ray crystal analyses (33, 82, 127). In Chapter 2, I have shown the 
enzymatic function of BioW as a pimeloyl-CoA synthetase with a unique proofreading 
activity. BioI is characterized as a cytochrome P450 due to its sequence homology and 
characteristic P450 spectral properties (43, 119). BioI has been shown to cleave carbon-
carbon bonds of free fatty acids to mixtures of dicarboxylic acids that include 
pimelate(119). BioI has also been reported to cleave the carbon-carbon bonds of acyl-
ACPs that co-purified with preparations of BioI expressed in E. coli (119) to give 
pimeloyl-ACP, albeit at sub-stoichiometric levels. The prior work plus the elegant crystal 
structures argued strongly that BioI provided the pimelate moiety required for B. subtilis 
biotin synthesis. Hence, B. subtilis seemed to have redundant systems in the first stage of 
the pathway. However two considerations weakened this argument.  First early genetic 
studies concluded that BioI function was not strictly required for biotin synthesis (10)  
and bacteria exist that encode BioW but lack genes encoding a recognizable BioI. I found 
that disruption of bioI fails to result in biotin auxotrophy whereas disruption of bioW 
results in a growth requirement for biotin. The auxotrophy of bioW mutant strains plus 
the BioW pimeloyl-CoA synthetase activity argued that free pimelic acid must be a biotin 
precursor. I report isotopic labelling studies that demonstrate this is the case and that the 
pimelate moiety is synthesized by the head-to-tail condensations of acetate units 
characteristic of fatty acid synthesis. 
 
 
 
36 
 
MATERIALS AND METHODS 
 
Materials and strains 
Sodium acetate (1-13C and 2-13C, each 99% enriched) was purchased from 
Cambridge Isotope Laboratories, Inc. Cerulenin, platencin, platensimycin and 8-amino-7-
oxononanoate were purchased from Cayman Chemical.  All other chemicals were 
purchased from Fisher Scientific or Sigma Aldrich. The bacterial strains are given in 
Table 3-1. The B. subtilis strains are all derivatives of strain 168 whereas the E. coli 
strains are derivatives of the wild type K-12 strains MC1061 or MG1655. The B. subtilis 
biotin overproducing strain BI274 and BI304 (derivatives of strain PY79 with 
constitutive expression of the bio operon) (11) were from the American Type Culture 
Collection (accession 55575 and 55573 respectively). The cer-20 derivative of B. subtilis 
168 that is partially resistant to cerulenin (115) was from the Bacillus Genetics Stock 
Center (accession 1A577).  
 
General growth media 
E. coli and B. subtilis strains were grown in LB media. The minimal medium for 
E. coli contained M9 salts, 0.4% glucose, 1 µg/ml thiamine and 0.1% Casamino acids. 
General defined media for B. subtilis was Spizizen salts consisting of  (NH4)2SO4; 0.2 %, 
K2HPO4; 1.4%, KH2PO4; 0.6%, sodium citrate · 2H2O; 0.1%, MgSO4 · 7H2O; 0.02% 
(118), plus trace elements [MgCl2·6H2O, CaCl2, FeCl2·6H2O, MnCl2·4H2O, ZnCl2, 
CuCl2·2H2O, CoCl2.6H2O NaMoO4.2H2O], 0.5% glucose, 0.04% potassium glutamate 
and 1 mM MgSO4 · 7H2O. Supplements required for growth included 0.01% tryptophan, 
1 mM sodium acetate, 0.1 mM each of branched chain fatty acid (BCFA) precursors 
(isobutyric acid, isovaleric acid and 2-methylbutyric acid). Genetic complementation 
experiments requiring expression of Pspac and PBAD promoters were performed in 
minimal media with 0.5% glycerol as the carbon source. Either isopropyl β-D-1-
thiogalactopyranoside (IPTG) (1 mM) or 0.2% arabinose was used for induction of the 
respective promoters. Antibiotics were used in the following concentrations (in µg/ml): 
chloramphenicol (5), erythromycin sulfate (1), lincomycin hydrochloride (25), 
spectinomycin sulfate (100), sodium ampicillin (100) and kanamycin sulfate (50).  
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Construction of bioW and bioI deletion mutant strains 
A 432 bp internal bioW fragment was amplified by PCR using primers: 5` GAG 
ATC GAA  TTC CCA TTC AGC CAT TGC 3` and 5` ATA ATG CGG CCG CTC ATT 
GCT GTA ATA CG 3`. The PCR product was digested with EcoRI and NotI and inserted 
into pMUTIN4 (123). The resultant recombinant plasmid was used to transform B. 
subtilis 168 to allow single crossover recombination of the nonreplicating plasmid into 
the chromosome. The transformants were selected on plates containing erythromycin and 
lincomycin. To disrupt bioI fragments of 570 bp and 627 bp corresponding to the 5` and 
3` region of bioI, respectively, were amplified with primers 5` ATC AGG GAT CCA 
AAT GAA GGC TAG TTT AAG 3`, 5` CAC TCC GAA TTC TGC TCC CTA TCT 
TCC 3` (5` region) and 5` CGG AC GTC GAC CAA CGG TCA ATC TCA TC 3`, 5` 
AAG CAC GGG CCC TTC ATA GTC TGA AAT AAG C 3`(3` region) and inserted 
into the BamHI-EcoRI (5`) and SalI-ApaI (3`) sites that bracket the kanamycin cassette 
of pDG780 (44). The recombinant plasmid encodes a bioI in which 75 internal codons 
were replaced with the kanamycin cassette. This plasmid was used to transform B. 
subtilis 168 and the recombinants resulting from a double-crossover recombination were 
selected on kanamycin-containing LB plates. Transformation of B. subtilis was carried 
out by the procedure of Dubnau and Davidoff-Abelson (27). 
 
For ectopic expression of bioW, the coding region was inserted into the SalI-SphI 
sites of pDR111. The recombinant plasmid was introduced into the bioW mutant strain by 
a double crossover recombination at the amyE locus. The gene disruption constructs were 
verified by colony PCR, restriction digestion and sequencing of the PCR products. The 
amyE phenotype was assayed on colonies grown for 16 h on LB starch plates by flooding 
the plates with 1% I2-KI solution (116). 
 
Growth of strain MM194 and purification of biotin from culture supernatants 
Strain MM194 was constructed by transformation of strain BI274 with the 
genomic DNA of NM57 (JH642 ∆lipM::Km) (84) with selection for ΔlipM mutants on 
kanamycin plates. The mutants were verified by the growth phenotype on minimal media 
and colony PCR. Strain MM194 was cultured overnight in LB and subcultured at the 
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final OD600 of 0.02 in minimal medium I which contained 0.05% yeast extract and 0.02% 
Bacto-Tryptone and allowed to grow at 37°C for 6-9 h until an OD600 ~2 was reached. 
Finally, the MMI culture was transferred to 1 L of minimal medium II which lacked yeast 
extract and tryptone but contained sodium acetate and BCFA at a final OD600 of 0.02 and 
allowed to grow overnight at 37°C for 15-18 h. 
 
 Cells were removed from 10-20 L cultures by centrifugation and the supernatant 
was filtered through Millipore 0.22 µm membranes. The supernatant was treated with 
activated charcoal and the charcoal was collected and extracted with an ethanol-
ammonium hydroxide mixture as described by Ogata (96). This extract was concentrated 
to a volume of 2 mL using Buchi Rotavapor R-210. N-hydroxysuccinimide-activated 
agarose (Pierce Thermo-Fisher Scientific) was used to covalently immobilize the F43A 
mutant derivative of shwanavidin, a dimeric avidin from Shewanella denitrificans (86) 
following the manufacturer protocol. Shwanavidin (20 mg) was coupled to 150 mg of 
agarose in coupling buffer (100 mM Na2HPO4, 150 mM NaCl at pH 7.2) by mixing at 4 
°C overnight. The shwanavidin-coupled agarose was washed twice in coupling buffer and 
any remaining N-hydroxysuccinimide groups were quenched with 1M Tris-HCL (pH 
7.4). Multiple loadings of 200-400 nmol biotin in the charcoal extract samples were 
allowed to bind to the shwanavidin-agarose complex by mixing at 4°C overnight. The 
agarose was then washed three times with coupling buffer. Most of the colored impurities 
were found in the flow-through and wash fractions with some loss of biotin. The bound 
biotin was then eluted with heated water (70°C) (52). Biotin was repeatedly determined 
by bioassay throughout the process of purification. The biotin samples obtained (~1 mg 
from 10 L cultures) were analyzed by Agilent 600 MHz NMR at the Carl R. Woese 
Institute for Genomic Biology, University of Illinois at Urbana-Champaign. D2O was 
used as solvent (pH ~13) and number of scans was 16,000nt. The biotin carbon atoms 
were assigned based on the 13C NMR shifts independently determined by Sanyal et al. 
(113) and Ifuku et al.(55). 
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Shwanavidin purification 
A synthetic gene encoding the F43A mutant derivative of Shewanella 
denitrificans shwanavidin was inserted into the NdeI-HindIII sites of vector pET28b to 
encode a protein with a N-terminal hexahistidine tag. The recombinant plasmid was 
transformed into expression strain BL21 (DE3) Tuner (Novagen) with selection for 
kanamycin resistance to obtain strain MM200.  Strain MM200 was grown overnight in 
LB medium and subcultured into 1 L of LB to allow growth up to OD600 of 0.8. The 
culture was induced with 1 mM IPTG for 3 h at 37°C. The cells were harvested after 
centrifugation and washed with 10 mM Tris-HCl, 100 mM NaCl and 1 mM EDTA (pH 
7.5). Cell pellets were suspended in 50 mM Tris-HCl, 200 mM NaCl, 1% Triton X-100, 
8% sucrose and 1mM phenylmethylsulfonyl fluoride at pH 8. Cells were lysed by 
passage through a French press and the lysate was centrifuged at 18,000 rpm for 30 min. 
The insoluble inclusion bodies were washed in the same buffer without Triton X-100 and 
centrifuged again to remove the buffer. The inclusion bodies were then dissolved in 6 M 
guanidine hydrochloride and 50 mM Tris-HCl (pH 7.5) to a concentration of 10 mg /mL 
and stirred slowly at 4°C for 4-6 h to allow equilibration. The solubilized protein was 
added dropwise into folding buffer (1/4 -1/2 of induced culture volume) of 50 mM Tris-
HCl, 150 mM NaCl, 5 mM EDTA and 0.1 mM phenylmethylsulfonyl fluoride at pH 7.5 
at 4°C while stirring and allowed to equilibrate overnight.  The solution was centrifuged 
to remove insoluble debris and dialyzed against 50 mM NaH2PO4, 500 mM NaCl and 
10% glycerol (pH 8). The partially pure protein was further purified using an ÄKTA 
protein purification system and a 5 mL HisTrap HP column. The pure protein was eluted 
with 150 mM imidazole in 50 mM NaH2PO4, 500 mM NaCl and 10% glycerol (pH 8). 
The protein was concentrated using 3K Amicon concentrator (EMD Millipore) and flash 
frozen at -80 °C in 50 mM NaH2PO4, 500 mM NaCl and 10% glycerol (pH 8).  
 
Mass spectral analyses  
Purified biotin samples were analyzed with Agilent LC/MS (Agilent 
Technologies, Santa Clara, CA). The LC separation was performed on an Agilent Eclipse 
XDB-C18 (4.6 x 50mm, 5μm) with mobile phase A (0.1% formic acid in water) and 
mobile phase B (0.1% formic acid in acetontrile). The flow rate was 0.4 mL/min. The 
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linear gradient was as follows: 0-2 min, 100% A; 6-17.5 min, 0% A. For high resolution 
mass spectra, the samples were analyzed by using the Q-Exactive MS system 
(Thermo, Bremen, Germany) of the Metabolomics Laboratory of the Carver 
Biotechnology Center, University of Illinois at Urbana-Champaign. 
 
Bioassay of biotin production 
E. coli strain NRD25 (15), which lacks the entire bio operon and strain ER90 
(∆bioF bioC bioD), which retains a functional bioB (14) were grown overnight in defined 
media containing 1 nM biotin. The cells were harvested by centrifugation, washed three 
times in M9 salts and allowed to starve in 100 mL of defined media containing 0.5 units 
of avidin for 5 h at 37°C. The biotin-starved cells were washed three times in 1mL M9 
salts and mixed with melted 1.5% agar containing defined media and 0.01% 2,3,5-
triphenyltetrazolium chloride, a redox indicator that develops a red color upon cellular 
respiration (17, 75). About 5 ml of medium was poured into plates quarter-sectored by 
plastic walls and sterile 6 mm disks (BD BBL blank test discs) was placed on top of the 
solidified agar. After spotting 10 µl of sample onto the disks the plates were incubated at 
30°C overnight. The amounts of biotin in the samples were quantitated by measuring the 
diameter of the red zone produced by known amounts of commercial biotin used as 
controls for every batch of minimal plates. 
 
Resting cell assays 
Strain BI274 cer-20 was constructed by transforming strain BI274 with the 
genomic DNA of the original cerulenin resistant strain and selection on LB plates 
containing 10 µg/ml cerulenin. The FabF mutation conferring increased cerulenin 
resistance (I108F) (115) was verified by sequencing. Strain BI274 and BI274 cer-20 were 
grown in LB media for 7-8 h at 37°C. The cells were subcultured to 400 mL of defined 
minimal media to a final OD600 of approximately 0.02 and incubated at 37°C for 16 h. 
The cells were harvested by centrifugation at 8000 rpm for 10 min and washed twice with 
Spizizen salts. Cells were transferred to 25 mL nitrogen-deficient minimal medium 
(Spizizen salts lacking ammonium sulfate) to a final OD600 of approximately 3 to 5. 
Aliquots were taken at several time points after adding antibiotics and the amount of 
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biotin released into the supernatant was determined by bioassay with E. coli strain ER90 
(ΔbioF bioC bioD) (14). The amount of biotin produced was quantitated by comparison 
to known amounts of control biotin assayed on the same batch of plates. 
 
RESULTS 
 
Expression of either B. subtilis BioW or BioI bypasses the biotin auxotrophy of an E. coli 
ΔbioC ∆bioH strain 
 The B. subtilis bioW and bioI coding sequences were inserted into the araBAD 
promoter vector pBAD322 (18) and the plasmid was introduced into strain STL25, a 
ΔbioC ∆bioH derivative of strain MG1655. Complementation of the E. coli ΔbioC ∆bioH 
strain was tested in biotin-free minimal medium supplemented with pimelic acid. The 
biotin auxotrophy of the mutant was successfully rescued by the induction of bioW gene 
expression with arabinose but only in the presence of pimelic acid (Figure 3-2A) as 
previously reported (10, 75). In contrast, basal level expression of bioI without arabinose 
induction was able to bypass the ΔbioC ∆bioH mutations even in the absence of pimelic 
acid, consistent with results obtained by Bower et al. (10) (Figure 3-2B). 
                                                                                                                                                                                                         
bioW is essential for biotin synthesis whereas bioI is dispensable  
 B. subtilis seems to contain two genes that serve the same purpose, generation of 
the pimelate thioester intermediate. In order to determine the importance of bioW and 
bioI, I constructed chromosomal gene disruptions. Vector pMUTIN4 was used to 
inactivate the chromosomal bioW gene by single-crossover homologous recombination 
and has an IPTG-inducible promoter (Pspac) positioned to drive expression of the 
downstream genes (123). Disruption of bioW caused biotin auxotrophy in biotin-free 
media (Figure 3-3A). Growth was rescued by expression of bioW from an IPTG-
inducible promoter at an ectopic chromosomal site (the amyE locus) (Figure 3-3A) 
demonstrating that the biotin auxotrophy is due to bioW inactivation and is not a polarity 
effect. Also, supplementation with dethiobiotin or 8-amino-7-oxononanoate rescued 
growth of the ∆bioW strain indicating that induction of the Pspac promoter prevented 
polar effects on expression of the downstream genes. 
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 In contrast, disruption of bioI failed to cause biotin auxotrophy. The strain grew 
as well in biotin-free minimal media as the wild type strain (Figure 3-3A).  It should be 
noted that the internal fragment deleted from bioI encodes several residues that position 
the acyl chain for attack by heme moiety (19). In the first studies of the B. subtilis bio 
operon insertion of an antibiotic resistance cassette into a site early in the BioI coding 
sequence resulted in strains that grew (albeit very slowly) in biotin-free minimal media 
(10). Moreover, a ∆bioW derivative of strain BI304 (11, 104) encoding a modified bio 
operon in which the terminator upstream of bioI was replaced with a constitutive strong 
promoter resulting in overexpression of BioI (104) failed to grow in biotin-free media.  
However, upon expression of a bioW gene integrated at the ectopic amyE locus this strain 
grew well (Figure 3-4). 
 
To provide a further test of the nonessential nature of BioI in B. subtilis biotin 
synthesis I tested the ability of the wild type strain 168 to grow anaerobically with nitrate 
as electron acceptor (93). The cytochrome P450 reaction requires molecular oxygen (81) 
and thus if BioI played an essential role in biotin synthesis growth should be blocked 
under these conditions. Two different anaerobic systems were tested, the BD Gaspak EZ 
Anaerobe Pouch System and a Coy anaerobic chamber containing 10% H2 - 90% N2. 
Growth proceeded in both systems regardless of the presence of biotin demonstrating that 
oxygen is not required for biotin synthesis (Figure 3-3B). Nitrate was required for growth 
confirming that the culture conditions were anaerobic. 
 
Free pimelic acid is a bona fide precursor of biotin synthesis in B. subtilis 
 The origin of pimelic acid in bacteria lacking the E. coli pathway remains a 
mystery. I carried out 13C-NMR experiments to test for the presence of free pimelic acid 
in vivo in B. subtilis and to begin to deduce a pimelate synthesis pathway. These 
experiments were analogous to previous studies in E. coli by Sanyal, Ifuku and 
coworkers (55, 113). In both studies, E. coli was grown in the presence of [1-13C]acetate 
or [2-13C]acetate and the labelling patterns of biotin extracted from the media was 
analyzed by 13C nuclear magnetic resonance (NMR). The authors ruled out free pimelic 
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acid as a biotin precursor in E. coli because the labelling patterns of biotin (and 
dethiobiotin) demonstrated that one of the pimelate carboxyl groups was fixed during 
synthesis possibly by a thioester bond. (If free pimelate was an intermediate, the biotin 
carbon atoms derived from the pimelate carboxyl groups would show the same labeling 
patterns due to the symmetry of pimelate.) Given that BioW is essential for biotin 
synthesis and activates free pimelate I expected a different result. Free pimelic acid is a 
rotationally symmetric molecule and thus the carbon atoms derived from the carboxyl 
groups would have the same labelling pattern. 
 
In this work I used B. subtilis strain BI274 which has an engineered bio operon 
driven by a phage SP01 promoter resulting in overproduction of biotin up to 1-2 mg/L of 
growth medium (11). B. subtilis cannot grow on acetate as sole carbon source because of 
the lack of a glyoxylate cycle and thus had to be grown on a more complex carbon 
source. In order to prevent dilution of the supplemented 13C-acetate by acetate produced 
from the glucose carbon source, I used a ∆lipM derivative of strain BI274 called strain 
MM194. The loss of LipM blocks lipoic acid synthesis which inactivates the essential 
lipoic acid-requiring enzymes, pyruvate dehydrogenase and branched-chain 
dehydrogenase (84).  However, loss of these enzymes can be bypassed by 
supplementation with acetate and branched chain fatty acid precursors which endogenous 
CoA ligases convert to their CoA esters (84).   
 
Strain MM194 was grown with either [1-13C]acetate or [2-13C]acetate as the sole 
acetate source to allow maximum enrichment of the 13C label into biotin (the branched 
chain precursors were also added) (Figure 3-5A). I then attempted to use the methods 
developed for E. coli to extract and purify biotin from the culture medium in sufficient 
amounts and purity to perform 13C nuclear magnetic resonance (NMR) analyses. 
However, although the recovery of biotin was good (Figure 3-5B), the resulting samples 
were much too impure for NMR.  Several additional purification steps were unsuccessful 
in ridding the samples of intensely colored contaminants. Finally I found that a mutant 
(F43A) derivative of shwanavidin, a dimeric avidin from Shewanella denitrificans (86) 
provided the needed purification. In native shwanavidin phenylalanine-43 acts to shield 
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bound biotin from solvent and its substitution with alanine results in a precipitous drop in 
the affinity of the protein for biotin to 10-8 M (86).  Expression in E. coli of a synthetic 
gene encoding the mutant shwanavidin gave abundant protein that was refolded 
immobilized on agarose. The impure biotin samples were bound to the shwanavidin 
F43A column, washed with three column volumes of 100 mM Na2HPO4 containing 150 
mM NaCl (pH 7.2) to remove the colored contaminants and biotin was eluted with water 
heated to 70°C. The elution conditions were those used to release biotinylated nucleic 
acids from streptavidin (52). Shwanavidin like other avidins is very heat tolerant and thus 
the column could be reused multiple times. 
 
As shown in Figure 3-6B, carbons 3, 10, 12 and 14 were enriched when [1-
13C]acetate was fed whereas when [2-13C]acetate was the acetate source carbons 7, 11 
and 13 were enriched (Figure 3-6C). Simultaneous 13C enrichment from [1-13C]acetate of 
the biotin carbon atoms derived from the pimelate carboxyl groups, carbons 3 and 14, 
provides strong evidence for the existence of free pimelate, a symmetrical molecule. In 
addition, the alternating pattern of enrichment of carbons from [1-13C]acetate and [2-
13C]acetate indicates that pimelate synthesis involves the head-to-tail chain elongations 
characteristic of fatty acid synthesis. The enrichments of the 13C-biotin samples used for 
NMR analysis were verified by high resolution electrospray ionization mass spectroscopy 
(Figure 3-7). The biotin samples labeled with [1-13C]acetate and [2-13C]acetate contained 
four and three 13C atoms, respectively, demonstrating that all of the acetate was derived 
from the supplements. The lack of dilution of the 13C-acetate supplements by 12C-acetate 
produced from the glucose carbon source indicates that the ∆lipM mutation completely 
inactivated the pyruvate dehydrogenase of strain MM194. 
 
Synthesis of pimelate depends on fatty acid synthesis in B. subtilis 
 In order to further explore the pimelate link between fatty acid and biotin 
synthesis, I carried out resting cell assays with fatty acid enzyme inhibitors and 
monitored the effects on biotin synthesis. I tested the effects of cerulenin (115), 
platensimycin and platencin, inhibitors of fatty acid elongation enzymes, FabF/FabB and 
FabH/FabF, respectively (131). Biotin production was determined by bioassay.  Resting 
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cell assays (cells starved for nitrogen) were used to avoid the difficulties of comparing 
inhibitor-free growing cultures to inhibited cultures that were unable to grow due to lack 
of lipid synthesis. 
 
Cerulenin at 10 µg/ml was found to inhibit the production of biotin by resting 
cells of strain BI274 by more than 70% (Figure 3-8) whereas 40 µg/ml cerulenin 
inhibited biotin production by more than 80% (Figure 3-8) indicating that the generic 
fatty acid elongation enzyme FabF, is required for biotin synthesis. Biotin synthesis was 
restored to 50% (at 10 µg/ml cerulenin) in the FabF [I108F] cerulenin-resistant derivative 
of strain BI274 (Figure 3-8) which is relatively insensitive to low concentrations of 
cerulenin (115). In addition, pimelic acid supplementation of cerulenin-treated resting 
cell cultures resulted in restoration of biotin synthesis to levels comparable to that of the 
untreated cultures whereas supplementation with glutaric acid had no effect (Figure 3-8). 
Therefore, the effects of cerulenin on biotin synthesis were due to blockage of pimelate 
synthesis. 
 
I also tested two other fatty acid synthesis inhibitors that to my knowledge had not 
been tested on B. subtilis. These were a dual FabH/FabF inhibitor, platencin (126), which 
inhibited biotin production by 19% when added at 1.9 µg/ml and platensimycin a FabF 
specific inhibitor (126), which inhibited biotin production by 15% at the same 
concentration (Figure 3-9). Note that the platencin and platensimycin experiments were 
limited by the expense of the antibiotics coupled with the relative insensitivity of B. 
subtilis to these molecules. 
 
DISCUSSION 
 
 The initial stage of B. subtilis biotin synthesis is markedly different from that of 
E. coli in that both the enzymes and thioester moieties differ (CoA in B. subtilis, ACP in 
E. coli). Although the presence of bioI and bioW in B. subtilis indicated a redundancy in 
the generation of the pimelate thioester intermediate, my data shows that bioW is the only 
bio gene essential for generation of the pimeloyl-CoA substrate of BioF. Bower et al. 
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reported that inactivation of bioW resulted in a biotin-requiring phenotype (10). However, 
growth was only partially restored by addition of dethiobiotin or 7, 8-diaminononanoate 
indicating polar effects on the downstream genes. In the bioW disruption construct I 
included a promoter oriented to transcribe the downstream genes. This was successful in 
that supplementation with late intermediates in the pathway completely restored growth. 
Moreover, complementation of the ∆bioW mutation by expression of wild type bioW 
from an ectopic site further demonstrated the absence of polar effects on the downstream 
genes. 
 
 My 13C-NMR data provide the first definitive evidence for the presence of free 
pimelic acid in B. subtilis cells. Following the rationale of Sanyal et al. and Ifuku et al. 
(55, 113) that eliminated free pimelic acid as a biotin precursor in E. coli, I conclude that 
the opposite situation is the case for B. subtilis. In the E. coli studies, free pimelic acid 
was ruled out as the precursor because upon incorporation into biotin the carbon atoms 
derived from the carboxyl groups of pimelate were not labelled symmetrically and thus 
are metabolically distinct. In contrast, my data showed that feeding experiments with [1-
13C]acetate enriched both of the biotin carbon atoms derived from the pimelate carboxyl 
groups indicating that free pimelic acid, a symmetrical molecule, is the precursor. In 
addition, my data also indicate fatty acid synthesis to be responsible for pimelate 
synthesis. This conclusion is based on the alternate pattern of assimilation of labelled 
carbons from [1-13C]acetate and [2-13C]acetate which indicate a head-to-tail 
configuration identical to the fatty acid chain elongation process. Resting cell assays with 
FabF inhibitors decreased biotin production indicating that fatty acid synthesis is 
involved in pimelate and hence, biotin synthesis. The effect of cerulenin on biotin 
production was more pronounced than with the other two inhibitors tested (note that B. 
subtilis is naturally resistant to two other fatty acid synthesis inhibitors, thiolactomycin 
and triclosan). I expect that the efficiency of cerulenin in inhibiting biotin production is 
probably due to its covalent interaction with FabF whereas platencin and platensimycin 
bind non-covalently (63). Moreover, platencin and platensimycin are poor inhibitors of B. 
subtilis growth.  The concentrations reported to inhibit Staphylococcus aureus were 
ineffective with B. subtilis. It should be noted that even inhibitors that almost completely 
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block fatty acid synthesis (e.g., cerulenin) might be expected to have less effect on biotin 
synthesis due to the fact that any residual fatty acid synthesis capacity could suffice for 
biotin synthesis given that fatty acids are made in great excess (ca. 104) over biotin. Note 
that I made numerous attempts to develop an in vitro B. subtilis cell extract system that 
would synthesize dethiobiotin starting from malonyl-CoA. A successful system would 
have allowed us to test intermediates and to overcome any cellular impermeability to 
inhibitors as was done using E. coli extracts (75).  However, this approach was 
unsuccessful, at best I saw only traces of dethiobiotin synthesis. Indeed, prior workers 
reported that B. subtilis extracts were almost totally deficient in synthesis of fatty acids 
that lacked terminal branching (13) which may have precluded synthesis of the straight 
chain pimelate molecule,.  
 
 The ability of B. subtilis BioI to support robust growth of E. coli ∆bioC ∆bioH 
strains in the absence of biotin indicated that the gene encodes a functional enzyme that 
almost certainly generates pimeloyl-ACP, a known intermediate in the E. coli pathway 
that readily explains the ∆bioC ∆bioH bypass. In B. subtilis the bioI transcript is 8-fold 
less abundant than the upstream bio operon transcript due to transcription termination 
(104). However, deletion of the terminator had only a very modest effect (<2-fold) on 
biotin production (104) and did not allow biotin synthesis in a ∆bioW strain. Hence, BioI 
does not play a detectable role in B. subtilis biotin synthesis even when overproduced and 
thus presents an enigma. Bower and coworkers reported that a ΔbioI mutation caused a 
bradytrophic phenotype in biotin-free media (10). However, I found that disrupting bioI 
failed to cause any growth defect. The ability of B. subtilis to grow anaerobically in 
biotin-free media further supported the results of my genetic data. If BioI, a cytochrome 
P450, was important for biotin synthesis B. subtilis would depend on oxygen for growth 
in biotin-free media. I hypothesize that acquiring bioW and making bioI extraneous 
during the course of evolution might have enabled B. subtilis to survive in environments 
where oxygen is scarce and other electron acceptors are available.  If so, bioW acquisition 
seems likely to have been a recent occurrence because the BioI sequence has not 
degenerated into an inactive protein. Consistent with this notion bioW is reported to have 
its own dedicated transcript in addition to the transcript that encodes bioW and other 
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genes of the operon (104) It should be noted that other bacteria that encode a BioW lack a 
BioI.  Some of these are Bacillus (now Lysinibacillus) sphaericus, S. aureus, Aquifex 
aeolicus and Chlamydia trachomatis. The methanogenic archaeon, Methanococcus 
jannaschii also encodes a BioW but lacks BioI consistent with it strictly anaerobic 
lifestyle. 
 
 The mechanism of the B. subtilis pimelate synthesis remains to be determined.  
The most straightforward pathway would be if the fatty acid synthetic pathway could 
accept a malonyl-thioester as a primer in place of the thioesters of the usual acetyl or 
branched chain precursors.  If so, when the pimelate chain was complete, it would be 
cleaved from ACP by a (presumably) specific pimeloyl-ACP thioesterase and BioW 
would convert the free pimelate to pimeloyl-CoA. Work to be published elsewhere 
argues that pimeloyl-CoA but not pimeloyl-ACP is a substrate for B. subtilis BioF. This  
pathway would be wasteful of ATP since an already activated pimeloyl carboxyl is 
cleaved and then reactivated, but since biotin synthesis is a very low demand pathway 
(36) there should be negligible effects on B. subtilis physiology. 
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TABLES AND FIGURES 
 
Table 3.1: E. coli and B. subtilis strains. 
a.The ∆bioF lesion is polar on bioC and bioD 
 
 
 
 
 
 
 
 
 
B. subtilis   
168 Wild type (132) 
MM43 ∆bioW of 168, downstream reading 
promoter 
This 
work 
MM57 ∆bioI of 168 This 
work 
MM59 MM43 with ectopic bioW This 
work 
PY79 Wild type (132) 
BI274 PY79 bio operon driven by strong 
constitutive SPO1-26 promoter 
(11, 
104) 
BI304  PY79 bio operon driven by strong 
constitutive promoter SPO1-15 and 
containing SPO1-15 in place of the 
terminator upstream of bioI [P15 bioWAFDB 
(Δt) P15 bioI] 
(104) 
MM194 ∆lipM of BI274 This 
work 
Cer-20 Cerulenin-resistant derivative of 168 (115) 
NM57 ∆lipM::Km (84) 
 
E. coli 
NRD25 ∆(bioABFCD)::Cm (15) 
ER90 ∆bioF bioC bioDa (14) 
STL25 ∆bioC ∆bioH (75) 
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Figure 3.1: The B. subtilis bio operon consists of bioW, bioA, bioF, bioD, bioB and bioI. 
The  arrow at the right indicates the promoter while the hairpin structure denotes the 
terminator upstream of bioI (104). The bio genes are transcribed from a promoter that is 
regulated in a biotin-dependent manner by the BirA, biotin protein ligase/repressor which 
binds to bioO, the operator sequence located upstream of bioW. 
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Figure 3.2: Complementation of the biotin requirement of the E. coli ∆bioC ∆bioH strain 
STL25 with B. subtilis bioW or bioI. A) B. subtilis bioW allowed growth of the E. coli 
∆bioC ∆bioH strain in biotin-free minimal media only upon supplementation with 
pimelic acid. Expression of bioW was induced from the PBAD promoter of vector 
pBAD322 by arabinose. Vector control indicates the empty vector induced with 
arabinose. Pimelic acid (0.1 mM) was used for growth supplementation. B) B. subtilis 
bioI allowed growth of the E. coli ∆bioC bioH strain without supplementation with either 
pimelic acid or arabinose. B. subtilis bioI was inserted into vector pBAD322. 
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Figure 3.3: Growth phenotypes of B. subtilis bioW and bioI mutant strains. A) 
Phenotypes of B. subtilis bioW and bioI deletion mutants. Deletion of the chromosomal 
bioW through single crossover recombination by integration of recombinant vector 
pMUTIN4 blocked growth in biotin-free minimal media. Two separate colonies were 
streaked into upper and lower sectors of the plates sectioned by plastic walls. IPTG (1 
mM) was used (left sectors, note the plus signs) to induce the expression of downstream 
genes whereas no IPTG was present in the right-hand sectors (minus signs). Expression 
of bioW from the Phyper-spank promoter of vector pDR111 inserted at an ectopic site 
(the amyE locus) restored growth only when promoter activity was induced with IPTG. 
No change in growth was observed when the chromosomal bioI gene was partially 
deleted and disrupted by insertion of the kanamycin cassette of plasmid pDG780.  The 
bioW strain was MM43 whereas the ∆bioI strain was MM57.  The derivative of MM43 
with an ectopic bioW was strain MM59 (104). B) Anaerobic growth of B. subtilis. B. 
subtilis 168 was streaked and incubated on biotin-free minimal medium plates with 
nitrate as the terminal electron acceptor using the BD Gaspak EZ Anaerobe Pouch 
System. Growth was dependent on nitrate but not biotin indicating that B. subtilis 
synthesizes biotin anaerobically and therefore the oxygen-dependent cytochrome P450 
enzyme, BioI is not required. The nitrate-dependent growth indicates that the conditions 
were anaerobic. 
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Figure 3.4: BI304 ΔbioW is unable to grow in biotin-free minimal media. BI304 is a 
strain in which the terminator preceding bioI is replaced with a constitutive promoter to 
allow overexpression of bioI (11). Top panel shows growth of all strains, indicated in the 
schematic, in biotin containing minimal media. Bottom panel shows growth of BI304 
(wild-type) in biotin-free minimal media whereas BI304 ΔbioW/ pbioW (wild-type bioW 
integrated into an ectopic amyE site) grows only in presence of IPTG, which induces 
expression of ectopic bioW.  
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Figure 3.5:  Acetate supplementation is required for growth and biotin production by 
strain MM194. A) Growth of strain MM194 with 1 mM sodium acetate and 0.1 mM each 
of the branched-chain fatty acid (BCFA) precursors isovaleric acid, isobutyric acid and 2-
methylbutyric acid. Strains BI274 and MM194 were grown overnight in minimal medium 
supplemented with yeast extract. Cells were harvested, washed twice in Spizizen salts 
and subcultured in a 96 well plate to a final OD600 of 0.012 in 300 µL of minimal media 
containing different growth supplements: (solid circles) BI274 without sodium acetate 
and BCFA precursors, (triangles) MM194 with sodium acetate and BCFA precursors, 
(squares) MM194 with BCFA precursors only, (diamonds) MM194 without acetate and 
BCFA precursors and (open circles) minimal media lacking cells. Strain BI274 grew 
without acetate and BCFA precursors whereas strain MM194 required both acetate and 
BCFA precursors for growth. B) Bioassay of biotin produced by strain MM194 plus 
acetate or BCFA precursors or both. Supernatants from the cultures were collected after 
growth on acetate and BCFA precursors and 10 µl of each was spotted into sterile paper 
disks on minimal agar plates containing the E. coli biotin auxotroph NRD25 
(∆bioABFCD::Cm). Production of biotin with acetate and BCFA precursors 
supplementation agrees with the growth dependence on these substrates (panel A). 
Known biotin amounts were used to quantitate biotin in each batch of the minimal plates 
used for bioassay. 
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Figure 3.6: 13C-NMR spectrum of biotin from [1-13C]acetate or [2-13C]acetate. A) 
Natural abundance 13C spectrum of commercial biotin gives peaks with chemical shifts 
corresponding to each of the biotin carbon atoms(55, 113).  Note that compared to my 
NMR program, Ifuku and Sanyal each use different biotin atom numbering systems.  My 
C14 is C1 of Ifuku and C10 of Sanyal whereas my C3 is C7 of Ifuku and C3 of Sanyal. 
B) Spectrum of 13C-enriched carbons from [1-13C]acetate. Carbons 3, 10, 12 and 14 of 
biotin (solid circles) are enriched with 13C.  Carbon atoms 3 and 14 are derived from the 
carboxyl carbons of pimelate. C) Spectrum of 13C-enriched carbons from [2-13C]acetate. 
Carbons 7, 11 and 13 of biotin (solid triangles) are enriched with 13C.  
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Figure 3.7: Electrospray ionization mass spectroscopy identification of 13C-biotin from 
A) [1-13C]acetate (calculated mass of 249.109) in the positive ESI mode and B) [2-
13C]acetate (calculated mass 246.090) in the negative ESI mode. The monoisotopic mass 
of biotin is 244.088. 
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Figure 3.8: Biotin production by untreated (white bars) and cerulenin treated (light gray 
bars) resting cell cultures of BI274 (WT) and BI274 cer-20 (cerulenin-resistant mutant) 
strains. The cells were grown in 400 mL of minimal media overnight. The cells were 
harvested, washed and transferred to nitrogen-limited medium in 25 mL culture volumes 
and allowed to incubate for 30 min at 37°C before treatment with 10 µg/ml of cerulenin 
(light gray bars). Samples (2 mL) were taken at the end of every hour up to 6 h and either 
0.1 mM pimelate (dark gray bars) or 0.1 mM glutarate (stippled bars) was added to the 
cerulenin-treated cultures and incubated for one additional hour before taking the final 
sample. Supernatants were harvested by centrifugation and filtered through a 0.22 µm 
membrane. Ten microliters of each sample was spotted onto paper disks placed on top of 
minimal medium plates containing a biotin auxotrophic strain of E. coli and a redox 
indicator (2,3,5-triphenyltetrazolium chloride) as in Figure 3-5. The percent of biotin 
production was calculated by comparing the amount of biotin produced with that of the 
untreated culture. The error bars represent standard errors.  In the seven repetitions of this 
experiment, 100% biotin production ranged from 6 to 25 pmol in the bioassays. The final 
biotin measurements for the antibiotic-treated cultures were determined after 6 h in each 
experiment.  
  
58 
 
 
Figure 3.9: Biotin production by resting cells of the wild type strain BI274 and BI274 
cer-20 its FabF (I108F) derivative. The methods were the same as in Figure 3-8 and 
Methods and Materials. Resting cells were treated with 5, 20 or 40 µg/ml of cerulenin in 
both panels whereas (left panel only) either 1.9 µg/ml of platencin or 1.9 µg/ml of 
platensimycin was added. The biotin contents of the supernatants were determined by 
bioassay. The error bars represent standard errors.  
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CHAPTER 4 
CONCLUSIONS 
 
SUMMARY OF FINDINGS 
 
The specific aim of this Thesis is to characterize the biotin biosynthesis pathway 
of Bacillus subtilis. Numerous studies in the past have successfully illustrated the 
mechanism of second half of the pathway that forms the two rings of the biotin molecule. 
However, our knowledge about the initial stage of biotin synthesis remained incomplete. 
Several conjectures existed to predict the synthesis of a pimelate (a seven-carbon α, ω-
dicarboxylic acid) moiety intermediate that separated the pathway into two distinct 
halves. The pimelate moiety was believed to be synthesized from acetate with CoA as the 
carrier molecule. In 2010, Lin et. al. demonstrated a mechanism used by Escherichia coli 
to synthesize its pimeloyl-ACP (thioester linkage with acyl carrier protein) intermediate 
by hijacking the fatty acid synthesis pathway. A SAM-dependent methyl transferase, 
BioC methylates malonyl-ACP to allow its entry into the fatty acid synthesis pathway by 
shielding the carboxyl group of the malonyl moiety. The malonyl moiety converts into 
pimeloyl moiety in two rounds of reduction, dehydration and reduction. BioH, a 
carboxylesterase cleaves the methyl ester to generate pimeloyl-ACP for the second stage 
of biotin synthesis. This mechanism of hijacking the fatty acid synthesis pathway for 
biotin production is present in organisms that contain bioC and bioH or their homologs. 
However, we know that there are several other organisms that do not have genes 
homologous to bioC and bioH. I chose B. subtilis has a model organism not only to study 
the other possible mechanisms of pimeloyl moiety generation but also to investigate the 
curious redundancy of the genes involved in pimelate moiety generation: bioI and bioW.  
 
In Chapter 2, I describe the unique characteristics of BioW as a pimeloyl-CoA 
synthetase. BioW is an atypical acyl-CoA ligase/synthetase capable in the ATP-
dependent conversion of pimelic acid to pimeloyl-CoA in a two-step reaction involving 
the formation of a pimeloyl-AMP intermediate (Figure 2-1A). I began characterizing 
BioW in the beginning of my Thesis work because the protein sequence had no 
60 
 
similarities with known acyl-CoA ligases and it was easily purified in large amounts. I 
discovered a unique function of BioW during enzymatic analysis. Apart from having the 
expected function of generating pimeloyl-CoA, BioW can also proofread noncognate 
substrates to ensure proper chain length incorporation into the biotin molecule. 
Noncognate substrates like glutaric acid (five-carbon α, ω-dicarboxylic acid, C5) and 
suberic acid (an eight-carbon α, ω-dicarboxylic acid, C8) can be eliminated by hydrolysis 
of the acyl-adenylate intermediate. The production of AMP (end product) in the absence 
of CoA (acceptor of acyl intermediate) provided a strong evidence for this conclusion. 
This is similar to pretransfer editing of aminoacyl-tRNA synthetase to choose the cognate 
amino acid from another similar in structure. These noncognate intermediates either 
hydrolyze spontaneously in solution after being removed from the enzyme or are 
hydrolyzed in the enzyme active site. I performed pH stability experiments to show that 
the hydrolysis takes place in the enzyme active site. Acyl-adenylates are prone to 
hydrolysis at higher pH. Increasing the solvent pH did not have an effect in the hydrolysis 
of noncognate acyl-adenylate intermediates. However, increasing the solvent pH 
increased the rate of hydrolysis of the cognate pimeloyl-AMP intermediate indicating the 
accessibility of solvent into the active site upon binding of cognate substrate. In absence 
of CoA, the rate of AMP production was linear with time in case of glutaric and suberic 
acid whereas pimeloyl-AMP saturated the enzyme active site. In conclusion, I showcased 
a unique proofreading ability of an uncommon acyl-CoA ligase, BioW.  
 
Despite the lack of evidence to show a link between BioW and aminoacyl-tRNA 
synthetases, this showed how B. subtilis avoids the expensive route to making an 
unusable derivative of biotin. Collaboration with Dr. Satish Nair and his group led to the 
crystallization of Aquifex aeolicus BioW that revealed a unique crystal structure of the 
protein (33). The structure contains a smaller N-terminal domain and a larger C-terminal 
domain with a modified Rossman fold common to nucleotide binding proteins (112). 
AaBioW also revealed proofreading activity of a noncognate substrate (C5) verifying the 
unique secondary function of an acyl-CoA ligase. This work made it possible to look at 
active site residues that interact with the substrates as well as test their role in the 
proofreading activity. Analysis on one of the AaBioW mutants provided evidence for the 
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role of single residue (Arg159) in the recognition of the cognate substrate. Wang and 
workers also recently illustrated the crystal structure of B. subtilis BioW that resembles 
the structure of A. aeolicus BioW (127). 
 
All prior studies characterized BioW as a pimeloyl-CoA synthetase. However, its 
role in the pathway was undefined given the presence of BioI, speculated as a source of 
pimeloyl-ACP. I started with a hypothesis that BioI is the major enzyme that supplies 
pimeloyl-ACP for biotin synthesis. This is because BioI is a well characterized 
cytochrome P450 with a crystal structure that clearly outlines the binding pocket where 
oxidation of long chain fatty acyl chains takes place to generate pimeloyl-ACP. However, 
previous studies showed genetic knockout of bioW caused biotin auxotrophy while 
removal of bioI merely caused a bradytrophic phenotype in B. subtilis PY79 prototrophic 
strain. In Chapter 3, I carried out bioW gene disruption by inserting plasmid pMUTIN4 
with an inducible promoter for the expression of downstream genes, to avoid polarity 
effects. This clearly caused biotin auxotrophy as previously described by Bower and 
coworkers (10). Ectopic expression of the wild-type bioW allowed restoration of growth 
in the bioW mutant. However, bioI disruption by insertion of kanamycin cassette did not 
have an effect on the growth of B. subtilis 168 in biotin-free minimal media. 
Additionally, I observed growth of B. subtilis 168 in anaerobic minimal media containing 
nitrate as the terminal electron acceptor, regardless of the presence of biotin. Since 
oxygen is required for a cytochrome P450 function, inactivation of BioI in anaerobic 
environment should have prevented B. subtilis growth. The insignificance of BioI in B. 
subtilis biotin synthesis is curious because bioI complements an E. coli ΔbioC ΔbioH 
mutant strain deficient in generating pimeloyl-ACP very well. The most straightforward 
explanation is that BioI might be a remnant of an oxygen-dependent strain of B. subtilis. 
Evolution may have favored acquisition of BioW to allow the organism to continue 
surviving in oxygen scarce environments. 
 
The importance of pimeloyl-CoA as the intermediate in biotin synthesis is 
established because of the significance of BioW. The question was where does BioW 
acquire free pimelate? Pimelate is not a common molecule and is not known to exist in 
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central metabolism. I attempted to decipher the source of pimelate by looking into 
genomic libraries of B. subtilis that could complement E. coli mutants for the lack of 
pimelate. I randomly mutagenized B. subtilis strain to uncover genetic elements 
responsible for pimelate synthesis. After years of failed attempts to discover the source of 
pimelate through genetic approaches, I concentrated my efforts to a different 
methodology- 13C-NMR. 
 
This approach is based on a previous study by Sanyal et al. (113) and Ifuku et al. 
(55) where they determined the origin of all carbons of the biotin molecule in E. coli 
from [1-13C]- or [2-13C]-labeled acetate. Since the labeling pattern in biotin was different 
from when E. coli cells were grown in [1-13C]acetate compared to [2-13C]acetate, they 
independently concluded that the pimelate moiety originating from acetate units has to be 
attached to a fixed end via a thioester linkage; thus, E. coli cannot use free pimelate for 
biotin synthesis. Pimelate is a symmetrical molecule which should incorporate into biotin 
resulting in a non-specific labeling pattern. B. subtilis on the other hand can use free 
pimelate for biotin synthesis so, this approach could be used not only to provide evidence 
for the presence of free pimelate in the cells but also as a guide to a pathway for pimelate 
synthesis.  
 
Maximum incorporation of 13C-acetate is essential to harvest pure highly enriched 
13C-biotin for NMR analysis. B. subtilis, unlike E. coli, cannot use acetate as sole carbon 
source due to lack of the glyoxylate cycle. I acquired a biotin overproducing strain 
(BI274) from a previous work that is patented by Bower and coworkers (11). I introduced 
a ΔlipM mutation into the strain to inactivate the lipoic acid requiring pyruvate 
dehydrogenase to block the supply of acetate from metabolized glucose used in the 
minimal media. The LipM mutation blocks lipoic acid synthesis required for pyruvate 
dehydrogenase and branched-chain dehydrogenase activity. Hence, the newly engineered 
strain could now use 13C-acetate and branched chain fatty acid precursors for growth in 
minimal media. Strain BI274 ΔlipM was grown in [1-13C]acetate or [2-13C]acetate in 
glucose containing minimal media. Twenty liters of B. subtilis culture was used to extract 
biotin in several steps of purification. The extract always consisted of a thick brown 
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coloring which was difficult to remove. Finally, affinity purification with a mutant 
derivative of shwanavidin, an avidin from Shewanella denitrificans, removed most of the 
colored contaminant. Biotin eluted with heated water was concentrated and dissolved in 
deuterium for NMR analysis. This protocol required several optimizations due to the 
necessity to keep biotin from contamination from organic solvents, which are detectable 
in 13C-NMR if present in abundant amounts.  
 
As expected, the label from [1-13C]acetate was incorporated into both terminal 
carbons arising from the pimelate molecule confirming the presence of the pimelate in B. 
subtilis. Additionally, the alternate labeling pattern of the valeric acid carbons from [1-
13C]acetate and [2-13C]acetate fed cultures indicated the involvement of a pathway 
similar to fatty acid synthesis for the synthesis of pimelate. Following up on this result, I 
tested the effect of several fatty acid enzyme inhibitors on biotin synthesis via a resting 
cell bioassay. If fatty acid synthesis is involved in supplying pimelate for biotin synthesis, 
blocking it with its inhibitors should have a negative effect on the production of biotin. I 
used resting cells of B. subtilis for this experiment to normalize the effect of cell growth 
in both the wildtype and mutant cells. Administration of cerulenin, a FabF inhibitor, had 
significant negative effect on biotin synthesis as seen in the bioassay media containing E. 
coli biotin auxotrophic strain. However, biotin production in a cerulenin resistant 
derivative was not as severely affected as in the wild-type strain. Additionally, 
supplementation of pimelate, but not glutarate, into the cerulenin treated cells restored the 
production of biotin to normal levels. Other inhibitors, platencin and platensimycin were 
not as effective in causing inhibition of biotin synthesis as was cerulenin.  
 
In summary, I have characterized one of the main enzymes that drives the initial 
step of biotin synthesis in B. subtilis and answered a long-standing question about the 
origin of pimelic acid. BioW is a pimeloyl-CoA synthetase which converts free pimelic 
acid to pimeloyl-CoA and proofreads noncognate dicarboxylic acid by hydrolyzing the 
reaction intermediate. This is the first demonstration of an acyl-CoA ligase having a 
function similar to an aminoacyl-tRNA synthetase. BioI, on the other hand, is not 
essential for biotin synthesis and appears to be an evolutionary remnant. The substrate of 
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BioW, pimelic acid has its origins linked to fatty acid synthesis. Although this link is 
analogous to the genesis of pimeloyl-ACP from fatty acid synthesis in E. coli, further 
details need to be uncovered to determine the true pathway for pimelate synthesis in B. 
subtilis.  
 
FUTURE DIRECTIONS 
 
Identification of preferred substrate of B. subtilis BioF: pimeloyl-CoA or pimeloyl-ACP 
I briefly introduced BioF in Chapter 1 as a 8-amino-7-oxononanoate synthase that 
carry out decarboxylative condensations between amino acids and carboxylic acid 
thioesters to form 8-amino-7-oxononanoate. In general, BioF is the enzyme that initiates 
the second stage of the pathway by utilizing the pimelate thioester intermediate (Figure 1-
2). Although I have shown BioI as a non-essential enzyme that produces pimeloyl-ACP, 
it would be interesting to compare the activity of B. subtilis BioF with pimeloyl-CoA and 
pimeloyl-ACP. 
 
The crystal structure of E. coli BioF is shaped like a left-hand palm with a deep 
cleft for substrate binding between the “thumb” and the “fingers” (2). Alexeev and 
coworkers speculated the cluster of positively charged arginine residues could be 
favorable binding site for phosphate of pimeloyl-CoA (Figure 4-1A, 4-2). However, they 
were unable to soak pimeloyl-CoA into the crystals to obtain a substrate-bound crystal 
structure. Obviously, this speculation was based on studies prior to the work of Lin et al., 
when pimeloyl-CoA, not pimeloyl-ACP, was thought to be the pimelate thioester 
intermediate. In hindsight, I can now predict that these positively charged residues might 
play a role in binding the acidic ACP protein. Although the activity of E. coli BioF has 
not been tested with pimeloyl-ACP to confirm this hypothesis, it is clear that E. coli BioF 
should prefer pimeloyl-ACP. I have shown the activity of E. coli BioF with pimeloyl-
ACP (Figure 4-3C) in a gel-shift experiment to show the conversion of pimeloyl-ACP to 
holo-ACP. Webster et al. (128) compared enzyme kinetics of E.coli BioF and B. 
sphaericus BioF with pimeloyl-CoA. They showed that the Km of E. coli BioF for  
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pimeloyl-CoA is 16-fold higher than that of the B. sphaericus BioF indicating that the E. 
coli enzyme has a much lower specificity for pimeloyl-CoA.  
 
The modeled structure of B. subtilis BioF is comparable to that of E. coli BioF. 
However, BsBioF model structure reveals interesting differences in key residues between 
the two proteins. The positively charged patch populated by arginine residues in E. coli 
BioF is replaced by polar uncharged glutamine or non-polar valine residues (Figure 4-2). 
This might be because B. subtilis BioF prefers a different substrate, pimeloyl-CoA, which 
may not require multiple charged residues for proper binding. E. coli BioF active site 
suited for ACP-bound substrate might be large enough to admit a CoA derivative since 
both ACP and CoA share the phosphopantetheine group. However, in case of B. subtilis 
BioF, the substrate binding site suited for a CoA-bound substrate may be too small to 
accept an ACP-bound substrate. It would be interesting to test this hypothesis by 
conducting site-directed mutagenesis replacing the native residues with either arginine or 
alanine to test for activity with pimeloyl-ACP (arginine substitutions) or loss of activity 
with pimeloyl-CoA (alanine substitutions). 
 
I have conducted some preliminary experiments to characterize BsBioF’s activity 
and its preference for pimeloyl-CoA. The protein was purified under denaturing 
conditions due to insolubility upon overexpression in E. coli (Figure 4-3A). Refolded 
BsBioF showed activity comparable to native B. sphaericus BioF, with pimeloyl-CoA 
(Figure 4-3B) but not with pimeloyl-ACP (Figure 4-3C). This clearly indicates that B. 
subtilis BioF prefers pimeloyl-CoA in in vitro reactions. I carried out an in vivo test to 
validate this result. E. coli BioF can complement B. subtilis ∆bioW mutant but not ∆bioW 
∆bioI mutant. The result clearly indicates that the product of BioI, pimeloyl-ACP, is used 
by E. coli BioF to restore the growth by bypassing the BioW reaction. Note that B. 
subtilis BioF cannot restore the growth in a ∆bioW mutant strain despite having a 
functional BioI that can produce pimeloyl-ACP. Further experiments can be done to 
analyze KAPA formation from reactions with either pimeloyl-CoA or pimeloyl-ACP to 
compare the activity of BioF with the two substrates. One could do that by conducting a 
bioassay on an E. coli BioF test strain. Another method would be to derivatize KAPA 
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with chemicals such as fluorescent dansyl-chloride to quantitate the amount of KAPA 
formed through LC/GC-MS.  
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FIGURES 
 
 
Figure 4.1: Crystal structures of E. coli BioF (left panel) and B. subtilis BioF (right 
panel). A) E. coli BioF is shaped like a left-hand palm with a deep cleft. The “thumb” is 
the N-terminal, the “fingers” make up the central domain, and the base of the palm is the 
C-terminal domain. A positive patch made up of arginine residues, represented in blue, is 
predicted to be the binding site of CoA. B) The model of B. subtilis BioF resembles the 
E. coli BioF structure. However, the arginine residues are replaced by uncharged 
glutamine or non-polar valine residues, represented in magenta. The image of E. coli 
BioF (1DJE) was downloaded from Protein Data Bank. B. subtilis BioF was modeled 
using Chimera. 
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Figure 4.2: Amino acid sequence alignments of BioF from E. coli, Bacillus cereus, 
Bacillus (now Lysinibacillus) sphaericus, Staphylococcus aureus, Bacillus 
amyloliquefaciens and B. subtilis using the amino acid sequence of E. coli BioF as 
template.  The black triangles represent the conserved active sites whereas the black 
circles represent the arginine residues that contribute to a positive patch for substrate 
binding.   
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Figure 4.3: B. subtilis BioF enzymatic activity. A) SDS-PAGE gel showing the 
purification of BsBioF under denaturing conditions. The molecular weight is 42.5kD. B) 
HPLC analyses of CoA formation from pimeloyl-CoA after reaction with B. sphaericus 
BioF (middle panel) or B. subtilis BioF (bottom panel) at 37°C for 1 hr. The top panel is 
a no enzyme control reaction showing the substrate, pimeloyl-CoA. C) Electrophoretic 
mobility shift assay showing reaction of E. coli BioF (lane 3), B. sphaericus BioF (lane 4) 
and B. subtilis BioF (lane 5) with pimeloyl-ACP as substrate to form holo-ACP. Lanes 1 
and 6 holo-ACP controls and lane 2 is a no enzyme control showing pimeloyl-ACP.  
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Figure 4.4: In vivo complementation assay in B. subtilis ∆bioW and ∆bioW ∆bioI 
mutants. The plates are sectioned into quarters by plastic walls. The schematic of the four 
quarter sections represent the strain streaked in each quarter. The plates contain biotin-
free minimal media either with (bottom plates) or without (top plates) IPTG. Bottom 
sections of all the plates contain two separate colonies of the mutant strain with E. coli 
bioF integrated in an ectopic site (amyE locus) in the chromosome. 
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